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ABSTRACT
	 	 	World-wide	 epidemiological	 studies	 have	 revealed	 that	 there	 is	 a	 strong	 linkage	 between	 inhaled	
indoor	air	pollutants	and	adverse	health	effects.	Typical	symptoms	experienced	by	the	exposed	subjects	
in	association	with	moisture	damage	are	airway	symptoms	such	as	cough,	phlegm,	wheezing	and	nasal	
symptoms.	Indoor	air	microbes	including Aspergillus fumigatus	can	also	cause	ocular	symptoms,	fatigue,	
headache,	joint	pain	and	nausea	in	the	exposed	individuals,	and	even	chronic	diseases	such	as	asthma	
have	been	reported.	In	addition,	degradation	of	polyvinyl	chloride	(PVC)	is	associated	with	an	increased	
prevalence	of	allergy,	asthma	and	dermal	symptoms.	However,	the	causal	health	impacts	of	these	indoor	
air	contaminants	are	not	well	understood.
	 	 	This	 study	 involved	 experimental	 challenges	 to	A. fumigatus	 and	degraded	PVC	 flooring	material	
or	 control	 challenges	 (allergen	 diluent,	 ceramic	 tile,	 respectively)	 and	 the	 active	 agent	 and	 control	
exposures	were	performed	in	a	random	order.	There	were	28	subjects	in	the	A. fumigatus	study	and	ten	
individuals	were	exposed	to	degraded	PVC.	The	effects	of	the	challenges	on	cytokine	and	nitric	oxide	
(NO)	concentrations	in	nasal	lavage	fluid	(NAL),	fractional	exhaled	NO	(FE
NO
)	and	nasal	NO	(FN
NO
)	
and	lung	functions	were	studied.	The	subjects	of	the	A. fumigatus	challenge	study	formed	three	groups:	
one	group	had	occupational	mould	exposure,	one	group	consisted	of	atopic	subjects	and	the	third	was	
a	 control	 group.	Those	10	 subjects	 participating	 in	 the	PVC	challenge	had	 experienced	occupational	
exposure	to	damaged	PVC	material.	In	addition,	the	short-term	and	seasonal	reproducibility	of	FE
NO
	and	
FN
NO
	measurements	techniques	used	in	the	challenge	studies	were	assessed.
			The	A. fumigatus	challenge	evoked	a	rapid	increase	in	FE
NO
	levels	and	there	was	a	significant	difference	
when	compared	to	control	challenge	(p<0.005)	and	the	changes	were	not	related	to	group.	On	the	next	
morning	after	the	A. fumigatus	challenge,	the	subjects	reported	significantly	more	often	respiratory	tract	
symptoms	compared	to	placebo	(p=0.014).	A. fumigatus	challenge	increased	the	levels	of	proinflammatory	
cytokines	IL-1β,	TNF-α	and	IL-6	in	the	subjects	with	the	most	distinct	change	being-observed	in	IL-1β.	
In	the	subjects	with	occupational	mould	exposure,	IL-4	concentrations	also	increased	significantly.	
	 	 	On	 the	 next	morning	 after	 the	PVC	challenge,	 the	 subjects	 reported	 significantly	more	 frequently	
respiratory	tract	symptoms	compared	to	control	exposure	(p=0.029).	The	PVC	challenge	did	not	affect	
the	levels	of	inflammatory	markers	or	lung	functions.	
	 	 	The	 short-term	and	 seasonal	variations	of	 the	FE
NO
	and	FN
NO
	measurements	 techniques	were	 low.	
Diurnal	variation	was	detected	and	the	measurements	performed	in	the	mornings	were	more	reproducible	
than	the	afternoon	values.
			In	conclusion,	due	to	rapid	increase	of	FE
NO
	levels	after	A. fumigatus	challenge	FE
NO
	measurement	can	
potentially	be	applied	in	the	assessment	of	acute	mould	exposure.	The	increased	cytokine	levels	provide	
a	link	between	biochemical	markers	and	acute	mould	exposure.	Degraded	PVC	material	evokes	airway	
symptoms	in	the	exposed	individuals	but	it	does	not	seem	to	cause	an	immediate	asthma-like	reaction.	
Serial	FE
NO
	and	FN
NO
	measurements	can	be	used	in	the	monitoring	of	respiratory	tract	inflammation.	Due	
to	the	diurnal	variation	of	FE
NO
	and	FN
NO
	in	long-term	follow-up,	the	measurements	should	be	performed	
at	the	same	time	of	day,	preferably	in	the	morning.
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1	INTRODUCTION
			Indoor	air	pollutants	in	damp	environments	are	a	major	public	health	concern	since	
they	are	associated	with	harmful	health	effects,	even	chronic	disease	(Bornehag	et	al.	
2001;	Health	Canada	2004;	National	Academy	2004).	A	wide	variety	of	symptoms	have	
been	reported	by	the	subjects	exposed	to	indoor	bioaerosols	including	upper	and	lower	
airway	symptoms,	conjunctival	symptoms	and	clusters	of	asthma		(Verhoeff	and	Burke	
1997;	Seuri	et	al.	2000;	Zureik	et	al.	2002).	Although	the	capability	of	indoor	air	microbes	
to	produce	secondary	metabolites	is	well	known	(Jarvis	and	Miller	2004),	the	question	
of	which	agents	in	the	indoor	air	contributes	to	the	adverse	health	outcomes,	remains	
unanswered.	Although	inflammatory	markers	such	as	proinflammatory	cytokines	and	
nitric	oxide	(NO)	have	been	linked	to	indoor	microbial	exposure	(e.g.	Hirvonen	et	al.	
1999;	Purokivi	et	al.	2001,	Roponen	et	al.	2001)	the	etiological	factors	linking	indoor	
air	bioaerosols	and	health	problems	are	still	unclear.
			Moisture-damage	in	a	building	is	thought	to	be	an	important	source	of	the	indoor	air	
problems	 both	 in	 residential	 and	 occupational	 environments	 (Bornehag	 et	 al.	 2001).	
In	 a	Finnish	 study,	 450	houses	were	 investigated	by	 civil	 engineers	 and	 in	 55	%	of	
them	were	found	to	suffer	from	moisture-damage	requiring	renovation	(Nevalainen	et	
al.	1998).	The	prevalence	of	significant	moisture	damages	in	buildings	was	evaluated	in	
Finland	in	the	1990s	and	estimated	to	be	as	high	as	50	%	depending	on	how	the	damages	
was	defined	(Nevalainen	et	al.	1998;	Koskinen	et	al.	1999).	The	proportion	has	been	
estimated	to	be	approximately	the	same	in	other	countries	with	similar	climates	e.g.	the	
northern	European	countries	and	North	America	(Brunekreef	et	al.	1989).	According	to	
a	recent		Finnish	questionnaire	study,		moisture	damage		was	reported		in	53	%	of	the	
1164	school	buildings	and	serious	mould	damage	with	visible	mould	growth	or	mould	
smell	in	26	%	of	the	schools	(Kurnitski	et	al.	1996).	
16
	 	 	 In	 addition	 to	 the	 adverse	 effects	 caused	 by	 the	microbial	 exposure	 as	 such,	 the	
microbial	growth	in	building	materials	may	lead	to	degradation	of	polyvinyl	chloride	
(PVC)	 flooring	materials	which	 release	phthalates	 that	 are	 also	hazardous	 to	 human	
health	and	may	cause	asthma	in	certain	sensitive	subjects	(Bornehag	et	al.	2005b).	Only	
few	markers,	except	for	IgE-mediated	sensitization	and	to	some	extent	IgG	antibodies,	
can	be	used	to	assess	exposure	in	the	subjects	residing	in	moisture	problem	buildings	
(Jarvis	and	Miller	2004).
	 	 	As	stated	before,	exposure	 to	 indoor	air	microbes	 is	associated	with	 inflammatory	
respiratory	 diseases	 and	 symptoms.	 Thus,	 an	 assessment	 of	 airway	 inflammation	
may	 serve	 as	 an	 indicator	 of	 the	 exposure.	One	 parameter,	 fractional	 exhaled	 nitric	
oxide	(FE
NO
)	measurement,	is	used	widely	in	clinical	work	for	assessing	lower	airway	
inflammation.	 For	 example,	 among	 asthmatics,	 the	 FE
NO
	 levels	 are	 significantly	
increased	when	compared	to	those	of	healthy	subjects	(Kharitonov	et	al.	1994).	Nasal	
nitric	oxide	(FN
NO
)	levels	can	be	used	for	examination	of	the	upper	airway	inflammation.	
Normally	the	FN
NO
	levels	are	clearly	higher	compared	with	FE
NO
	levels	(Jorissen	et	al.	
2001).	Nasal	lavage	fluid	(NAL)	sampling	represents	a	simple	and	non-invasive	way	to	
investigate	upper	respiratory	tract	inflammation	(Steerenberg	et	al.	1996).
			In	an	attempt	to	investigate	the	health	effects	associated	with	exposure	to	microbes	
present	in	water-damaged	buildings,	we	utilized	two	different	approaches.	In	this	study,	
it	 was	 assessed	 if	 experimental	 Aspergillus fumigatus	 and	 degraded	 PVC	 flooring	
material	challenges	could	affect	FE
NO	
and	FN
NO
	levels,	lung	functions	and	nitric	oxide	
(NO)	and	cytokines	in	NAL.	Short-term	and	seasonal	reproducibility	of	the	FE
NO
	and	
FN
NO
	measurement	techniques	used	in	this	study	were	also	assessed.
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2	REVIEW	OF	THE	LITERATURE
2.1	Health	problems	related	to	moisture-damaged	buildings
			According	to	epidemiological	data,	exposure	to	the	complex	mixture	of	microbes	and	
other	chemical	compoments	of	indoor	air	in	moisture-damaged	buildings	is	associated	
with	a	variety	of	symptoms	(Bornehag	et	al.	2005;	Portnoy	et	al.	2005).	Most	often	the	
subjects	have	experienced	upper	and	lower	airway	irritation	symptoms	such	as	cough,	
phlegm,	blocked	or	itching	of	the	nose,	dyspnoea,	wheezing,	sore	throat	or	hoarseness	
(Ruotsalainen	et	al.	1996;	Seuri	et	al.	2000;	Purokivi	et	al.	2001).	The	other	symptoms	
include	ocular	distress,	headache	and	joint	pain	(Verhoeff	and	Burke	1997;	Roponen	
et	al.	2001)	and	there	is	even	a	cluster	of	idiopathic	pulmonary	hemosiderosis	(IPH)	in	
infants	exposed	to	fungal	mycotoxins	at	their	moisture-damaged	homes	(Dearborn	et	al.	
1999).	The	irritation	symptoms	among	the	mould	exposed	subjects	have	been	linked	to	
endotoxins,	β(1-3)-glucans	and	microbial	volatile	metabolites	(MVOC)	(Rylander	1998;	
Korpi	2001;	Douwes	2005).	In	addition,	fungal	volatile	substances	have	an	unpleasant	
smell	which	 can	 lead	 to	 psychological	 symptoms	 such	 as	 nausea	 and	 fatigue	 in	 the	
occupants	of	moisture-damaged	buildings	(Portnoy	et	al.	2005).
			It	has	been	claimed	that	exposure	to	indoor	air	fungi	is	associated	with	exacerbation	of	
asthma	in	mould-sensitive	asthmatics	(Zureik	et	al.	2002;	National	Academy	of	Sciences	
2004)	and	clusters	of	asthma	have	been	found	among	occupants	of	moisture-damaged	
buildings	 (Smedje	 et	 al.	 1996;	 Seuri	 et	 al.	 2000;	 Bornehag	 et	 al.	 2001).	Moreover,	
increased	risk	of	asthma	has	been	shown	to	be	related	to	the	presence	of	visible	mould	or	
mould	smell	in	occupational	situations	(Jaakkola	et	al.	2002).	Allergic	responses	such	as	
asthma,	allergic	rhinitis	and	organic	dust	toxic	syndrome	(ODTS)	are	the	most	common	
medical	problems	associated	with	inhalation	exposure	to	fungi	(Jarvis	and	Miller	2004).	
In	a	Finnish	study,	mould	odour	and	visible	mould	in	the	workplace	were	connected	to	
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the	risk	of	asthma	(Jaakkola	et	al.	2002).	However,	in	a	prospective	cohort	study,	only	
mould	odour	was	strongly	associated	with	increased	risk	of	developing	asthma	whereas	
other	 indicators	of	mould	exposure	such	as	history	of	water	damage,	moisture	in	 the	
inferior	surfaces	and	visible	mould	did	not	predict	asthma.	In	addition,	the	joint	effect	
of	parental	atopy	and	mould	odour	in	asthma	development	was	weaker	than	expected	
(Jaakkola	et	al.	2005).
			A	total	of	70	fungal	allergens	have	been	characterized	and	among	atopic	subjects	the	
prevalence	of	fungal	allergy	ranges	from	20-30	%	compared	to	6	%	in	general	population	
(Kurup	 et	 al.	 2000;	 2002).	 It	 has	 been	 reported	 that	 e.g.	Alternaria, Cladosporium, 
Aspergillus	 and Penicillium	 species	 are	 linked	 to	 the	 development	 of	 atopic	 disease	
(Husman	1996;	Kurup	2000).	On	the	other	hand,	fungal	allergy	has	not	been	associated	
with	microbial	exposure	 in	symptomatic	schoolchildren	 (Taskinen	et	al.	1997;	1998;	
2002).	These	data	indicate	that	there	are	also	pathways	other	than	IgE-mediated	allergy	
that	mediate	 the	 adverse	 health	 effects	 of	 indoor	 air	microbes	 and	 that	 non-allergic	
inflammatory	 responses	 seem	 to	 play	 an	 important	 role.	Elevated	 serum	 fungal	 IgG	
antibody	levels	have	been	found	in	farmers	with	extensive	occupational	mould	exposure	
(Erkinjuntti-Pekkanen	et	al.	1999).	In	a	previous	study,	which	examined	teachers	with	
indoor	 air	 mould	 exposure,	 the	 increased	 fungal-specific	 IgG	 concentrations	 were	
associated	with	a	higher	prevalence	of	sinusitis	 (Patovirta	et	al.	2003).	However,	 the	
presence	of	fungal	IgG	antibodies	in	human	sera	indicates	only	that	an	exposure	has	
occurred	at	some	time	in	the	past	(Jarvis	and	Miller	2004).
			In	Finnish	population-based	incident	case-control	study	an	increased	risk	of	developing	
asthma	in	adulthood	was	significantly	related	to	IgG	antibodies	to	T. citrinoviride,	but	
not	to	the	other	moulds	including	Aspergillus fumigatus, A. versicolor, Cladosporium 
cladosporioides, Fusarium oxysporum, Sporobolomyces salmonicolor, Stachybotrys 
chartarum, and Streptomyces albus (Jaakkola	et	al.	2002).
			In	moisture-damaged	buildings,	the	concentrations	of	viable	fungi	and	bacteria	(101-
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104	cfu/m3)	are	generally	not	much	higher	than	those	in	reference	buildings	(Hyvrinen	
2002).	However,	visible	mould	or	dampness	has	been	often	linked	to	increased	indoor	
air	fungal	levels	(Johanning	et	al.	1999;	Hyvrinen	et	al.	2001;	Meklin	et	al.	2003).	In	
addition,	there	are	several	studies	indicating	that	remediation	of	the	mouldy	environment	
can	decrease	irritation	symptoms	among	the	occupants	compared	to	situation	before	the	
renovation	(hman	et	al.	2000;	Jarvis	and	Morey	2001;	Patovirta	et	al.	2004)	linking	
the	symptoms	to	exposure	in	these	buildings.	On	the	other	hand,	toxicological	studies	in	
vitro	and	in	vivo	have	shown	clear	differences	between	these	microbial	strains	in	their	
ability	 to	 induce	 cytotoxicity	 and	 inflammatory	 responses	 (Ruotsalainen	 et	 al.	 1998;	
Huttunen	et	al.	2000).	Moreover,	 the	growing	conditions	may	significantly	affect	 the	
evoked	responses	(Hirvonen	et	al.	2001;	Murtoniemi	et	al.	2001).
2.1.1	Microbes	indicating	moisture	damage	in	buildings
			In	moisture	damaged	buildings,	certain	microbial	species	normally	not	found	indoors,	
start	 to	grow	on	 the	wet	material.	The	microbes	 that	can	be	considered	as	 indicators	
of	 a	 moisture	 problem	 are	 mostly	 moulds	 but	 also	 yeasts	 and	 bacteria	 are	 found	
(Andersson	 et	 al.	 1996)	These	microbes	 include	 bacteria	 such	 as	 actinobacteria	 and	
non-enteric	gram-negative	bacteria,	yeasts	and	several	fungi	like	Aspergillus	fumigatus,	
Aspergillus	versicolor,	Exophiala,	Fusarium,	Phialophora,	Stachybotrys,	Trichoderma	
and	Ulocladium	(Samson	et	al.	1994;	Hyvrinen	et	al.	2002).	They	occur	in	clusters	of	
species	with	the	most	important	factor	regulating	the	growth	being	the	available	water,	
defined	as	water	activity	(aw)	(Jarvis	and	Miller	2004).	Spores	of	these	microbes	can	
become	airborne	and	then	can	be	inhaled	into	the	airways	(Burge	2002)	but	no	obvious	
threshold	value	can	be	defined	below	which	no	adverse	health	effects	occur	due	to	the	
fact	that	some	microbes	seem	to	be	more	harmful	than	others.	Nonetheless,	it	has	been	
generally	considered	that	exposure	to	an	average	of	more	than	1000	colony	forming	units	
(cfu)/m3	in	the	indoor	air	represents	a	potential	health	risk	(Flannigan	et	al.	1991).	
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	 	 	 The	 microbial	 elements	 that	 might	 be	 recognized	 by	 the	 host	 and	 which	 might	
evoke	activation	of	the	immune	system	are	the	spore,	hyphae	or	part	of	the	cell	wall.	
They	include	a	wide	variety	of	molecules	such	as	proteins,	polysaccharides	linked	to	
proteins,	lipids	and	carbohydrates.	The	immune	system	responds	to	microbial	cell	wall	
components	through	innate	immune	receptors	such	as	Toll-like	receptors	(Netea	et	al.	
2004).	In	addition,	some	proteins	and	glycoproteins	may	also	be	allergenic	and	trigger	the	
activation	of	the	adaptive	immune	system	in	susceptible	individuals.	Chitin,	a	common	
cell	 wall	 constituent	 of	 moulds,	 has	 also	 been	 shown	 to	 have	 immunomodulatory	
properties	in	airway	inflammation	(Strong	et	al.	2002).	
	 	 	Many	of	 the	filamentous	fungal	species	found	in	damp	buildings	produce	harmful	
secondary	metabolites	 such	as	mycotoxins	 (Bennet	 and	Klich	2003).	Animal	 studies	
have	reveald	 that	mycotoxins	evoke	both	cytotoxic	and	 inflammatory	changes.	They	
also	disrupt	cellular	structures	and	interfere	with	vital	cellular	processes	such	as	RNA	
Figure 1. Microscopic view of Aspergillus fumigatus showing typical columnar, 
uniseriate conidial heads (© Dr David Ellis, School of Molecular and Biomedical 
Science, The University of Adelaide, Australia). 
21
and	 DNA	 synthesis	 (Jarvis	 and	Miller	 2004).	 In	 addition	 to	 mycotoxins,	 fungi	 can	
also	produce	other	 secondary	metabolites	 that	are	potent	 immunostimulators	 such	as	
enzymes	with	protease	or	proteolysing	activities.	This	is	of	special	interest	since	those	
proteases	have	been	observed	to	trigger	the	production	of	pro-inflammatory	cytokines	
in	vitro	(Kauffman	et	al.	2000).	
	 	 	 Microbial	 volatile	 compounds	 (MVOC)	 are	 compounds	 accounting	 for	 mouldy	
odours	and	they	are	considered	to	evoke	respiratory	symptoms	in	the	mould	exposed	
individuals	(Norbck	et	al.	1999).	It	has	been	shown	that	most	building	structures	release	
MVOCs	into	the	indoor	air	and	the	production	of	these	compounds	is	not	only	typical	
for	microbes	(Korpi	2001).
2.1.2	Aspergillus fumigatus
   Aspergillus fumigatus was	investigated	in	this	study	and,	therefore,	it	will	be	examined	
in	more	detail.	
   A. fumigatus	 is	a	fungus	 that	has	been	 isolated	frequently	from	moisture-damaged	
buildings	in	and	its	presence	linked	with	a	variety	of	upper	and	lower	airway	symptoms	
in	the	occupants	(Hyvrinen	et	al.	1999).	Within	the	Aspergillus	spp,	A. fumigatus,	a	
saprophyte	 fungus,	which	 grows	 on	 large	 variety	 of	 organic	 remains.	These	 species	
causes	a	wide	range	of	diseases	including	organic	dust	toxic	syndrome	(ODTS),	allergic	
reactions,	asthma,	allergic	alveolitis,	allergic	bronchopulmonary	aspergillosis	(ABPA)	
and	systemic	diseases	such	as	invasive	aspergillosis	(IA)	witch	has	mortality	ranging	
from	60	to	as	high	as	90	%	(Tekaia	and	Latge	2005).	In	immunodeficient	individuals	
(e.g.	 patients	who	 have	 undergone	 transplants,	 patients	with	 leukaemia	 or	HIV)	 the	
inhalation	of	A. fumigatus	conidia	may	lead	to	fatal	consequences	(Rementeria	et	al.	
2005).	There	are	several	reports	linking	aspergillosis	to	increased	airborne	levels	of	A. 
fumigatus	spores	(Andersson	et	al.	1996;	Loo	et	al.	1996;	Oren	et	al.	2001).
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			Since	the	conidia	of	A. fumigatus	are	small	in	size	(from	2	to	3	µm)	they	can	remain	
in	the	environment	for	a	long	time	(Figure	1).	They	can	reach	the	pulmonary	alveoli	
in	individuals	constantly	inhaling	the	air	in	which	they	are	suspended	(Latge	1999).	A. 
fumigatus	secretes	highly	toxic	secondary	metabolites	such	as	gliotoxin,	fumagilin	and	
helvolic	acids	which	are	considered	to	cause	the	adverse	health	effects	(Fischer	et	al.	
2000).
			Inhalation	of	A. fumigatus	conidia	by	an	immunocompetent	individual	activates	the	
innate	 cellular	 system	 (alveolar	 macrophages,	 neutrophils)	 which	 is	 responsible	 for	
killing	of	the	conidia.	Conidial	dihydroxynaphthalene-melanin	has	been	recognized	as	
a	virulence	factor	of	A. fumigatus	and	it	is	present	on	the	conidial	surface.	On	the	other	
hand,	A. fumigatus	 is	 a	 saprotrophic	 fungus	 that	 becomes	 a	 pathogen	 due	 to	 simple	
biological	reasons:	it	is	present	in	high	concentrations	in	the	atmosphere,	it	grows	faster	
than	any	other	airborne	fungi	at	40	°C	and	it	can	overcome	the	defence	system	of	the	
host	when	the	host	has	a	very	weak	or	impaired	defence	immunity	(Tekaia	and	Latge	
2005).
	 	 	 Indoor	 air	 exposure	 to	A. fumigatus	 can	 evoke	 an	 IgE-mediated	 allergic	 reaction	
(Zureik	et	al.	2002)	and	a	typical	Th2-type	response,	including	the	elevated	IL-4	levels,	
dominates	the	immune	response	(Schuh	et	al.	2003).	In	addition,	production	of	the	anti-
inflammatory	cytokine,	IL-10,	is	also	enhanced	and	it	has	been	estimated	to	diminish	
both	Th1-	 and	Th2-type	 responses	 evoked	 by	A. fumigatus	 (Schuh	 et	 al.	 2003).	On	
the	other	hand,	it	has	been	reported	that	fungal	allergy	(including	A. fumigatus)	is	rare	
among	symptomatic	 subjects	exposed	 to	 indoor	air	microbes	of	a	moisture-damaged	
building	 (Taskinen	 et	 al.	 1997).	Thus,	 there	 are	 also	mechanisms	 other	 than	 allergy	
involved	in	evoking	the	symptoms	attributed	to	A. fumigatus.	In	addition,	part	of	the	IgE	
binding	to	mould	and	yeast	allergen	extracts	is	explained	by	cross-reacting	glycoproteins	
and,	therefore,	false-positive	IgE	and	skin	prick	test	results	need	be	taken	into	account	
in	any	diagnosis	of	mould	allergy	(Leino	et	al.	2006).	On	the	other	hand,	there	is	also	
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epidemiologic	evidence	that	sensitization	to	A. fumigatus	as	well	as	to	Cladosporium 
herbarum	indicated	by	specific	IgE	is	related	to	the	risk	of	adult-onset	asthma	(Jaakkola	
et	al.	2006).
2.2	Degraded	PVC	materials	and	adverse	health	effects
			Polyvinyl	chloride	(PVC)	is	synthesized	by	polymerization	of	vinyl	chloride	monomers.	
PVC	is	a	hard	plastic	material	that	is	softened	by	plasticizers	such	as	phthalates.	PVC	is	
an	important	product	in	the	chemical	industry	since	it	has	a	wide	range	of	applications	
including	building	materials,	food	packaging,	credit	cards,	clothing,	toys	and	medical	
devices.	
	 	 	 Diethylhexyl	 phthalate	 (DEHP)	 and	 di-isononyl	 phthalate	 (DINP)	 are	 the	 best-
known	phthalates	that	release	from	degraded	PVC	products.	Most	of	the	environmental	
monitoring	data	is	devoted	to	DEHP,	almost	2	million	tons	of	which	is	produced	world-
wide	each	year.	The	major	source	of	human	exposure	to	DEHP	is	contaminated	food	
e.g.	 during	 production	 or	 packaging	 but	 the	 next	 important	 source	 is	 the	 indoor	 air.	
Degradation	of	PVC	flooring	material	may	result	in	the	release	of	DEHP	into	the	indoor	
air	where	the	agent	adheres	to	aerosols	which	are	then	inhaled	by	the	exposed	subjects	
(National	Toxicology	Program,	2000).
			Damaged	PVC	materials	have	been	related	to	asthma	and	allergy.	Already	in	the	70s,	
some	 reports	described	occupational	asthma	among	meat	wrappers	who	are	exposed	
to	pyrolysis	products	of	PVC	when	cutting	the	wrapper	with	hot	wire	rod	(Sokol	et	al.	
1973,	Andrasch	et	al.	1976).	In	addition,	epidemiologic	studies	have	shown	increased	
risk	of	ocular	and	respiratory	symptoms	and	asthma	among	meat	wrappers	compared	
with	unexposed	staff	(Polakoff	et	al.	1975,	Falk	and	Portnoy	1976).	Øie	et	al.	(1997)	
suggested	that	DEHP	can	bind	into	the	surface	of	building	materials,	particles	etc.	leading	
to	large	concentrations	gaining	access	to	the	respiratory	organs.	They	also	suggested	that	
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the	plastic	materials	are	potential	sources	of	chemical	emission	into	indoor	air	which	
may	cause	inflammation	and	elevate	the	risk	of	asthma.
	 	 	Wieslander	et	al.	 (1999)	and	Norbck	et	al.	 (2000)	have	studied	nasal,	ocular	and	
asthmatic	 symptoms	 in	 relation	 to	 building	 dampness	 and	 the	 degradation	 of	 PVC	
flooring	 material	 among	 87	 workers	 of	 four	 geriatric	 hospitals.	According	 to	 their	
studies,	release	of	the	DEHP	from	PVC	flooring	causes	conjunctival	and	nasal	irritation	
and	 increases	asthma-like	symptoms	 in	 the	exposed	subjects.	They	also	detected	 the	
PVC	degradation	product	2-ethylhexanol	in	indoor	air	samples.
			Jaakkola	et	al.	(1999;	2000)	have	published	studies	on	the	problems	associated	with	
plastic	 materials	 at	 home	 and	 how	 this	 impacts	 on	 the	 respiratory	 health	 of	 young	
children.	They	concluded	that	the	chemical	emissions	from	PVC	materials	into	indoor	
air	 could	 cause	 adverse	 respiratory	 effects.	Bornehag	 et	 al.	 (2004)	 described	 a	 dose	
response	relationship	among	children	between	asthma	prevalence	and	the	concentrations	
of	DEHP	 in	 settled	dust.	 In	addition,	 it	has	been	 reported	 that	DEHP	concentrations	
were	higher	in	buildings	erected	before	1960	(Bornehag	et	al.	2005a).	That	could	reflect	
higher	fractional	concentrations	in	older	products	or	higher	emission	rates	as	products	
degrade.	It	has	been	claimed	that	the	combination	of	water	leakage	at	home	and	PVC	as	
flooring	material	in	the	rooms	was	associated	with	a	higher	prevalence	of	symptoms	in	
the	exposed	subjects	compared	to	only	water	leakage	(Bornehag	et	al.	2005b).
			Phthalate	esters	have	been	proposed	to	act	as	either	allergens	or	adjuvants	(Jaakkola	
et	 al.	 1999;	Øie	 et	 al.	 1997)	 but	 even	 though	 there	 is	 a	 strong	 association	 between	
health	problems	and	PVC	materials,	the	etiological	factors	causing	the	symptoms	are	
still	unclear.	However,	it	has	been	shown	in	animal	models	that	phthalates	can	cause	
death	and	malformations	of	foetuses.	They	are	also	animal	carcinogens	and	toxic	to	the	
reproductive	system	(Tyl	et	al.	1988;	Li	et	al.	1998).
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2.3	Occupational	lung	diseases	and	exposure	to	indoor	air	bioaerosols
			Occupational	lung	disease	is	a	work-related	illness	based	on	the	frequency,	severity	
and	preventability	of	diseases.	These	illnesses	have	been	attributed	to	due	to	extensive	
exposure	to	irritating	or	 toxic	substances	that	may	cause	acute	or	chronic	respiratory	
ailments.	World-wide,	asthma	is	the	most	common	occupational	lung	illness	followed	
by	 asbestosis,	 mesothelioma,	 occupational	 lung	 cancer,	 byssinosis,	 coal	 workers’	
pneumoconiosis	and	allergic	alveolitis	(National	Institute	for	Occupational	Safety	and	
Health	2002).	In	Finland,	306	new	occupational	asthma	cases	were	diagnosed	during	the	
year	2002,	and	the	moulds	of	moisture-damaged	buildings	were	the	largest	responsible	
factor	causing	this	disease	being	responsible	for	79	cases	(Piipari	and	Keskinen	2005).
		 	Increased	prevalence	of	occupational	disorders	including	respiratory	tract	irritation	
symptoms,		allergic	rhinitis,	asthma	and	allergic	alveolitis	(e.g.	“farmers	lung	disease”)	has	
been	reported	in	association	with	extensive	bioaerosol	exposure	in	farmers	(Erkinjuntti-
Pekkanen	et	al.	1999;	Kimbell-Dunn	et	al.	2001),	waste	treatment	and	compost-handling	
workers	(Wouters	et	al.	2002)	and	sawmill	workers	(Mandryk	et	al.	2000).	There	are	
also	reports	showing	that	exposure	to	indoor	air	fungi	and	phthalates	may	evoke	asthma	
in	some	individuals	(Zureik	et	al.	2002;	Jaakkola	et	al.	1999;	2000).	As	stated	before,	
Aspergillus fumigatus is	 a	 well-known	 indicator	 microbe	 of	 mould	 damages	 (Hyv
rinen	et	 al.	 1999)	which	can	cause	a	variety	of	 respiratory	disease	 including	asthma	
(Rementeria	et	al.	2005;	Jaakkola	et	al.	2006).	Thus,	occupational	exposure	in	moisture	
and	mould	damaged	work	environment	may	lead	to	the	development	of	occupational	
asthma	induced	by	A. fumigatus.
			In	Finland,	the	diagnostic	investigations	of	mould-induced	asthma	are	performed	in	
central	hospitals	or	in	the	Finnish	Institute	of	Occupational	Health	(FIOH).	Skin	prick	
tests	 (SPT)	and	 specific	 IgE	antibodies	 to	 the	most	 common	moulds	 are	determined	
and	the	peak	expiratory	flow	(PEF)	values	are	followed	at	home	and	at	the	workplace.	
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Definite	diagnoses	are	based	on	challenge	tests	 to	moulds	which	have	been	found	in	
the	material	or	indoor	samples	from	the	workplace.	In	practice,	there	are	commercial	
challenge	extracts	only	for	A. fumigatus,	Cladosporium cladosporioides	and	Acremonium 
kiliense	(Piipari	and	Keskinen	2005).
2.4	Biochemical	markers	of	respiratory	tract	inflammation
2.4.1	Immune	responses
			The	immune	response	is	how	the	body	recognizes	and	defends	itself	against	harmful	
substances	such	as	bacteria,	viruses	and	fungi.	An	essential	component	of	the	immune	
system	protection	is	the	way	that	the	cells	recognize	and	respond	to	the	antigens	which	
are	large	molecules	on	the	surface	of	cells,	viruses,	bacteria	or	fungi.	After	recognition,	
the	immune	system	destroys	micro-organisms	containing	the	antigens.
			Innate	immunity	means	barriers	such	as	skin,	mucus	and	the	cough	reflex	that	prevent	
harmful	antigens	from	gaining	access	to	the	body.	It	relies	on	receptors	such	as	Toll-like	
receptors	(TLRs)	and	nucleotide-binding	oligomerization	domains	proteins	(NOD-like	
receptors,	NLRs)	which	alert	the	immune	system	of	the	invading	microbes	(Albiger	et	
al.	2007).	In	contrast,	acquired	immunity	is	the	type	of	immunity	that	occurs	when	the	
body	 has	 been	 exposed	 to	 harmful	 antigens	 and,	 consequently,	 represents	 a	 specific	
defence	 against	 harmful	 antigens.	 Lymphocytes	 have	 an	 important	 role	 in	 acquired	
immunity	and	they	will	be	described	more	detailed	later.
			The	inflammatory	response	results	in	inflammation	which	represents	tissue	injury	in	
the	inflamed	area.	The	damaged	tissues	release	vasoactive	chemicals	such	as	histamine,	
bradykinin	and	serotonin	which	lead	to	fluid	leakage	from	blood	vessels.	Subsequently,	
the	 tissues	 swell	 which	 prevents	 antigens	 from	 achieving	 further	 tissue	 contact.	 In	
addition	to	swelling,	typical	signs	of	inflammation	are	redness,	pain	and	warmth	in	the	
inflamed	area	(Medical	Encyclopedia	2006).			
			Nitric	oxide,	cytokines	and	inflammatory	cells	will	be	described	in	detail	as	a	part	of	
immune	response	in	airways.	
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2.4.2	Nitric	oxide
	 	 	Nitric	oxide	(NO)	is	a	potent	biological	mediator	and	it	has	an	important	role	in	a	
wide	variety	of	cellular	and	tissue	functions.	Previously,	NO	was	regarded	as	a	noxious	
environmental	pollutant	but	later	several	studies	revealed	that	it	is	an	essential	molecule	
in	the	human	body	(Fabio	et	al.	2004).	The	existence	of	NO	in	exhaled	air	of	healthy	
subjects	was	originally	reported	by	Gustafsson	et	al.	(1991).	Later,	it	was	shown	that	
NO	is	clearly	increased	in	exhaled	air	of	asthmatic	subjects	(Kharitonov	et	al.	1994).
			NO	is	synthesized	from	the	amino	acid	L-arginine	and	three	isoforms	of	NO	synthase	
(NOS)	enzymes	have	been	described	(Moncada	et	al.	1993;	Nathan	et	al.	1993).	In	the	
airways,	NO	participates	in	many	different	functions	such	as	mediation	in	inflammation,	
bacteriostatic	and	virostatic	activity,	and	dilatation	of	bronchial	smooth	muscle	(Fabio	
et	al.	2004).
			The	NOS	enzymes	which	form	the	system	responsible	for	NO	production	were	originally	
identified	by	Bult	et	al.	(1990).	Molecular	cloning	and	protein	purification	methods	have	
revealed	three	distinct	isoforms	of	NOS:	inducible	NOS	(iNOS),	constitutive	neuronal	
NOS	 (nNOS)	 and	 constitutive	 endothelial	NOS	 (eNOS).	Each	of	 the	 three	 isoforms	
has	a	characteristic	tissue-specific	expression	and	all	the	isoforms	are	expressed	in	the	
airways	(Lamas	and	Michel	1997).	NO	derived	from	the	constitutive	isoforms	nNOS	
and	eNOS	(cNOS)	has	been	found	to	moderate	the	bronchomotor	tone.	In	contrast,	NO	
derived	from	the	iNOS	isoform	has	been	indicated	to	be	a	proinflammatory	mediator	
(Fabio	et	al.	2004).	iNOS	isoform	levels	are	induced	by	many	triggers	e.g.	cytokines	
IL-1β,	TNF-α	and	IFN-γ	(Morris	and	Billiar	1994).	After	exposure	the	iNOS	produces	
large	amounts	of	proinflammatory	NO	and	these	high	levels	may	be	sustained	for	several	
hours	(Fabio	et	al.	2004).	In	a	recent	case	report,	acute	purulent	sinusitis	was	triggered	
by	topical	nasal	administration	of	an	NO	synthase	inhibitor	(Lundberg	2005).
			In	addition	to	several	inflammatory	diseases,	elevated	NO	concentrations	have	been	
measured	in	NAL	after	exposure	to	indoor	air	microbes	(Hirvonen	et	al.	1999;	Roponen	
et	al.	2001).	On	the	other	hand,	it	has	been	claimed	that	the	presence	of	nitric	oxide	alone	
is	an	insufficient	biomarker	of	exposure	to	microbes	in	a	moisture-damaged	building	
(Purokivi	et	al.	2002).
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2.4.3	Inflammatory	cells
			Macrophages	are	large	phagocytic	cells	secreting	proinflammatory	and	antimicrobial	
mediators	and	they	have	a	major	role	in	innate	and	adaptive	immunity	(Gordon	1999).	
These	cells	exist	in	several	tissues	such	as	connective	tissue	(histiocytes),	liver	(Kupffer’s	
cells),	lung	(alveolar	macrophages),	lymph	nodes	(free	and	fixed	macrophages),	spleen	
(free	and	fixed	macrophages),	bone	marrow	(fixed	macrophages),	serous	fluids	(pleural	
and	peritoneal	macrophages)	 and	 skin	 (histiocytes,	Langerhans’s	 cell).	Macrophages	
have	 also	 been	 classified	 according	 to	 how	 they	 are	 activated.	 Classically	 activated	
macrophages	 exhibit	 a	 Th1-like	 phenotype	 promoting	 inflammation,	 extracellular	
matrix	(ECM)	destruction	and	apoptosis.	Instead,	alternatively	activated	macrophages	
display	 a	 Th2-like	 phenotype,	 promoting	 ECM	 construction,	 cell	 proliferation,	 and	
angiogenesis.
			Neutrophilic	granulocytes	are	peripheral	blood	cells	which	account	for	constituting	
normally	99	%	of	the	circulating	polymorphonuclear	cells.	The	granules	of	neutrophils	
contain	 lysozyme,	myeloperoxidase	 (MPO)	 and	 human	 neutrophil	 lipokalin	 (HNL).	
Neutrophils	 are	 involved	 in	 acute	 inflammatory	 responses,	 acting	 as	 a	 first	 line	 of	
defence	against	invading	micro-organisms.	In	the	inflammatory	context,	the	neutrophils	
are	known	 to	produce	proinflammatory	cytokines	 (TNF-α	and	IL-1β),	CC	and	CXC	
chemokines,	 macrophage	 inflammatory	 protein	 (MIP-1α)	 and	 angiogenic	 factors	
(Kasama	et	al.	2005).
			Eosinophil	granulocytes	are	produced	in	bone	marrow	and	they	are	normally	found	
in	 peripheral	 blood	 and	 gut	 lining.	 Eosinophils	 are	 essential	 mediators	 of	 allergic	
inflammation	 and	 increased	 eosinophil	 levels	 have	 been	 detected	 in	 atopic	 disease	
such	 as	 asthma	 and	 allergic	 rhinitis	 (serum,	 sputum)	 and	 also	 in	 parasitic	 infections	
(Keatings	and	Barnes	1997).	Hypereosinophilic	syndrome	(HES)	is	a	rare	disorder	that	
is	 characterized	 by	 persistent	 and	marked	 eosinophilia	 combined	with	 organ	 system	
dysfunction	 (Wilkins	 et	 al.	 2005).	 As	 a	 response	 to	 inflammation	 eosinophils	 can	
produce	eosinophil	peroxidase	(EPO),	eosinophil	protein	X	(EPX),	oxygen	radicals	and	
cytokines	(IL-5,	IL-6,	TNF-α).
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			Lymphocytes	are	divided	into	two	broad	categories	called	T-	and	B-lymphocytes.	T-
cells	play	an	important	role	in	cell-mediated	immunity	whereas	B-cells	are	primarily	
responsible	for	humoral	immunity.	T-lymphocytes	are	grouped	to	CD4	and	CD8	cells,	
and	the	CD4	cells	are	further	divided	according	to	which	cytokine	types	they	produce.	
CD4	 cells	 are	 subgrouped	 to	Th1	 cells	 producing	 IFN-γ	 and	Th2	 cells	 inducing	 the	
production	of	 IL-3,	 IL-4,	 IL-5	and	 IL-10.	Th2	cells	are	activated	 in	atopic	disorders	
whereas	IFN-γ	inhibits	IgE	production	in	B-lymphocytes	(Schuh	et	al.	2003).
2.4.4	Cytokines
			Cytokines	are	small,	soluble	and	multifunctional	polypeptides	produced	by	a	variety	
of	 cells.	 Epithelial	 and	 inflammatory	 cells	 in	 the	 nasal	 mucosa	 can	 secrete	 several	
cytokines	 such	 as	TNF-α,	 IL-1β,	 IL-4,	 IL-6	 and	 interferon	 gamma	 (IFN-γ)	 (Barnes	
et	al.	1998;	Opal	et	al.	2000).	The	human	immune	response	 is	 regulated	by	a	highly	
complex	network	of	agents	and	cytokines	form	an	essential	part	of	this	entity.	Cytokines	
modulate	leukocytes	and	structural	cells	during	inflammatory	and	immune	responses.	
They	are	able	to	eliminate	pathogens	by	a	number	of	approaches	including	free	radical	
generation	and	phagocytic	activation.	The	cytokines	are	capable	of	evoking	(e.g.	via	
TNF-α,	 IL-1β)	or	suppressing	 the	 inflammation	(e.g.	via	IL-10)	(Schuh	et	al.	2003).	
Cytokines	IL-1β,	IL-4,	IL-6,	IL-12,	TNF-α	and	IFN-γ	were	assessed	in	this	study	and	
they	are	reviewed	in	more	detail.
			IL-1β	is	a	proinflammatory	cytokine	mainly	produced	by	airway	macrophages	as	a	
part	of	the	non-specific	inflammatory	response.	It	stimulates	expression	of	endothelial	
adhesion	molecules	 and	 chemokines	 and	 enhances	 the	 production	 of	NO	 (Barnes	 et	
al.	1998;	Opal	et	al.	2000).	 IL-1β	 stimulates	 the	production	of	TNF-α	which	 is	also	
a	 proinflammatory	 cytokine	 (Yoshimura	 et	 al.	 2003).	 In	 a	 similar	manner	 to	 IL-1β,	
TNF-α	stimulates	the	expression	of	endothelial	adhesion	molecules	but	also	stimulates	
the	 recruitment	 of	 neutrophils	 and	monocytes	 in	 inflammation	 (Barnes	 et	 al.	 1998).	
Increased	levels	of	IL-1β	and	TNF-α	in	nasal	lavage	fluid	(NAL)	have	been	detected	
after	mould	exposure	in	a	moisture	damaged	building	(Purokivi	et	al.	2001)	and	exposure	
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to	swine	dust	(Wang	et	al.	1997).	TNF-α	is	expressed	by	various	cell	types	including	
lymphocytes,	eosinophils,	macrophages,	monocytes	and	epithelial	cells	(Barnes	et	al.	
1998).
	 	 	 IL-6	 is	 also	 a	proinflammatory	 cytokine	but,	 on	 the	other	hand,	 it	 can	 inhibit	 the	
production	 of	 TNF-α	 and	 IL-1β	 and	 may	 protect	 the	 host	 cells	 from	 potentially	
destructive	inflammatory	responses	(Opal	et	al.	2000).	IL-6	is	known	to	stimulate	the	
synthesis	of	acute-phase	proteins	and	the	growth	of	B	lymphocytes	and	it	is	expressed	by	
lymphocytes,	monocytes,	macrophages,	epithelial	cells,	fibroblasts	and	smooth	muscle	
cells	(Barnes	et	al.	1998).	Several	studies	have	reported	increased	IL-6	levels	in	NAL	
after	exposure	to	indoor	air	microbes	of	moisture-damaged	buildings	(Hirvonen	et	al.	
1999;	Purokivi	et	al.	2001;	Roponen	et	al.	2001).	The	spores	of	Aspergillus versicolor,	
isolated	originally	from	the	indoor	air	of	a	moisture-damaged	building,	have	been	shown	
to	cause	acute	inflammation	in	mouse	lungs	assessed	as	a	dose-dependent	increase	in	
the	levels	of	proinflammatory	cytokines	(TNF-α,	IL-1β	and	IL-6)	in	bronchoalveolar	
lavage	fluid	(BALF).	This	was	confirmed	by	the	presence	of	histopathological	changes	
in	the	lungs	(Jussila	et	al.	2002).
			T	cells	are	divided	into	subsets	based	on	cytokine	production.	Those	cells	that	produce	
IFN-γ	 are	 called	Th1	cells	 and	 those	producing	 IL-4	 are	designated	Th2	cells.	Mast	
cells	can	generate	IL-4,	while	the	natural	killer	cells	are	an	important	source	of	IFN-γ.	
IL-4	promotes	the	Th2-type	response	and	it	is	connected	to	allergy	and	atopic	disease.	
In	addition,	 the	Th2-type	response	 including,	 the	elevated	IL-4	levels,	dominates	 the	
immune	 response	 in	A. fumigatus	 induced	 diseases	 such	 as	 pulmonary	 aspergillosis	
(Schuh	et	al.	2003).	Elevated	IL-4	levels	in	NAL	have	been	found	in	association	with	
occupational	mould	exposure	(Roponen	et	al.	2001).	Th1-type	cytokine	IFN-γ	inhibits	
IL-4	 production	 and	 cell	 proliferation	 and	 also	 enhances	 the	 cytotoxicity	 of	TNF-α	
(Barnes	et	a.	1998).	It	has	been	demonstrated	that	the	development	of	an	IFN-γ	producing	
capacity	during	the	first	3	months	of	life	is	associated	with	farming,	the	existence	of	
endotoxin	in	house	dust	and	cat	and	dog	exposure	(Roponen	et	al.	2005).
			IL-12	inhibits	the	production	of	Th2-type	cytokines	and	enhances	the	Th1-induced	
differentiation	and	proliferation	(Nutku	et	al.	2001).	Increased	IL-12	levels	have	been	
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detected	 in	 several	 respiratory	 disorders	 e.g.	 in	 rhinovirus	 infections	 (Ferreira	 et	 al.	
2002).
2.5	Non-invasive	methods	for	airway	inflammation	assessment
	 	 	Several	non-invasive	methods	have	been	developed	 for	assessing	 respiratory	 tract	
inflammation.	 In	 this	 study,	 fractional	 exhaled	 (FE
NO
)	 and	 nasal	 (FN
NO
)	 nitric	 oxide	
(NO)	measurements,	 lung	 function	 tests	 including	 spirometry	 and	diffusion	 capacity	
(DLCO)	 and	 the	 assessment	 of	 cytokine	 concentrations	 in	 nasal	 lavage	 fluid	 (NAL)	
were	 used	 and,	 therefore,	 they	will	 be	 described	 in	 detail.	However,	 determining	 of	
inflammatory	markers	from	induced	sputum	and	exhaled	breath	condensates	(EBC)	are	
also	widely	used	non-invasive	techniques	to	assess	airway	inflammation	(Effros	et	al.	
2004;	Brightling	2006).	
2.5.1	Fractional	exhaled	and	nasal	nitric	oxide	measurements
			Direct	measurements	of	FE
NO
	and	FN
NO
	are	performed	by	means	of	chemiluminescence	
analysis.	The	instruments	developed	for	the	NO	measurement	are	based	on	technology	
dating	from	the	1970’s	which	were	originally	used	for	environmental	and	atmospheric	
analyses	 (Fontjin	 et	 al.	 1970).	 	 FE
NO
	measurement	 techniques	 are	 nowadays	widely	
used	in	clinical	work	in	the	assessment	of	lower	airway	inflammation.	Both	ATS	and	
ERS	have	provided	recommendations	on	how	the	FE
NO
	and	FN
NO
	measurements	should	
best	be	done	 (Kharitonov	et	al.	1997;	ATS	1999;	ATS/ERS	2005).	The	experimental	
data	 show	 that	 the	 normal	 FE
NO
	 values	 of	 healthy	 subjects	 range	 from	 10-20	 ppb	
but	there	is	not	a	full	consensus	about	the	reference	values	(Smith	and	Taylor	2005).	
Conventionally,	the	FE
NO
	and	FN
NO
	measurements	have	required	the	presence	of	several	
pieces	of	bulky,	non-portable	equipment.	Novel	hand-held	devices	for	NO	measurements	
have	been	developed	and	are	claimed	to	be	suitable	for	clinical	studies	(Alving	et	al.	
2006).	In	addition	to	the	previously	reported	techniques,	new	off-line	methods	for	FN
NO
	
measurement	have	been	developed	(Oh	et	al.	2004).
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			The	FE
NO
	levels	have	been	found	to	be	inversely	correlated	to	exhalation	flow	rate	and	
therefore	a	fixed	flow	rate	of	50	mLs־	has	been	recommended	(Kharitonov	et	al.	1997;	
ATS	1999).	It	has	been	found	that	higher	exhalation	flow	rates	(250	vs.	500	mL/minute)	
lead	to	larger	intraday	and	inter-day	variabilities	in	FN
NO
	measurement,	and	the	FN
NO
	
levels	are	inversely	related	to	the	flow	rate	(Silkoff	et	al.	1999).
			The	baseline	levels	of	FN
NO
	are	high	compared	to	FE
NO,
	with	the	highest	levels	being	
reported	in	paranasal	sinuses	(Lundberg	et	al.	1999;	Jorissen	et	al.	2001).	At	present,	
there	is	no	standardized	technique	for	measuring	FN
NO
	and,	thus	the	levels	measured	
from	different	laboratories	vary	from	30	to	2000	ppb	(Jorissen	et	al.	2001).		This	has	
been	explained	as	being	attributable	to	the	different	measurement	techniques	(Silkoff	et	
al.	2001;	Jorissen	et	al.	2001).	
			The	short-term	reproducibility	of	FE
NO
	measurement	techniques	(intraday,	day-to-day,	
week-to-week)	is	high	according	to	several	studies	(Ekroos	et	al.	2000;	Ekroos	et	al.	
2002;	Kharitonov	et	al.	2003).	The	reproducibility	of	FN
NO
	has	not	been	investigated	as	
extensively	as	FE
NO
	but,	however,	the	short-term	variation	of	FN
NO
	has	been	indicated	
as	being	low	(Bartley	et	al.	1999;	Palm	et	al.	2000;	Kharitonov	et	al.	2005).	In	spite	of	
the	intense	interest	in	the	assessment	of	NO,	it	is	surprising	that	there	are	so	few	studies	
about	the	long-term	reproducibility	of	FE
NO
	and	FN
NO
	measurement	techniques.	This	is	
an	important	 issue	because	FE
NO
	and	FN
NO
	measurements	provide	excellent	 tools	for	
long-term	follow	up	of	an	individual’s	airway	inflammatory	status.
	 	 	 It	has	been	stated	that	FE
NO
	levels	 increase	in	asthma	and	decline	from	these	high	
levels	 as	 a	 response	 to	 corticosteroid	 treatment	 (Kharitonov	et	 al.	 1994;	Fabio	 et	 al.	
2004).	FE
NO
	may	also	reflect	disease	severity	and	clinical	control	of	asthma,	particularly	
during	exacerbations	(Kharitonov	et	al.	1996;	Sippel	et	al.	2000).	FE
NO
	levels	correlate	
in	asthmatic	patients	with	airway	hyperresponsiveness	to	metacholine,	peak	expiratory	
flow	 values	 and	 eosinophilic	 inflammation	 as	 determined	 in	 blood,	 bronchoalveolar	
lavage	(BAL)	and	sputum	(Fabio	et	al.	2004).	
	 	 	 The	 role	 of	 FE
NO
	 in	 COPD	 is	 conflicting.	 Current	 smokers	 with	 severe	 COPD	
(particularly	 in	 combination	 with	 cor	 pulmonale)	 show	 lower	 FE
NO
	 levels	 than	 ex-
smokers	who	have	mild	or	moderate	COPD	(Clini	et	al.	2000).	Smoking	is	known	to	
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decrease	FE
NO
	and	FN
NO
	levels	(Persson	et	al.	1994)	but	after	smoking	cessation,	oral	
NO	increases	again	to	normal	levels	(Robbins	et	al.	1997).
	 	 	Other	 disorders	 associated	with	 increased	FE
NO
	 levels	 are	 rhinitis,	 bronchiectasis,	
active	 pulmonary	 sarcoidosis,	 active	 fibrosing	 alveolitis	 and	 acute	 lung	 allograft	
rejection	(Fabio	et	al.	2004).	In	contrast,	low	levels	of	FE
NO
	have	been	linked	to	primary	
ciliary	dyskinesia	 (PCD),	cystic	 fibrosis	 (CF),	PiZZ	phenotype-related	α
1
-antitrypsin	
deficiency	and	pulmonary	hypertension	(Fabio	et	al.	2004).	
	 	 	 In	 the	 occupational	 environment,	 inhalation	 of	 organic	 dust	 from	 swine	 houses	
increased	the	levels	of	FE
NO
	in	the	exposed	occupants	(Sundblad	et	al.	2002).	Traffic-
related	air	pollution	has	also	been	linked	to	peak	FE
NO
	levels	among	exposed	subjects	
(Steerenberg	et	al.	2001).	In	addition,	latex	allergen	exposure	is	known	to	increase	FE
NO
	
concentrations	(Baux	and	Barbinova	2005).	
			Low	levels	of	FN
NO
	have	been	detected	in	CF	and	both	acute	and	chronic	sinusitis	
(Lundberg	 and	 Weizberg	 1999).	 There	 are	 controversial	 data	 about	 the	 FN
NO
	
concentrations	in	rhinitis.	Several	studies	have	reported	increased	FN
NO
	levels	in	patients	
with	allergic	rhinitis	(Lundberg	and	Weizberg	1999)	but,	in	contrast,	no	alterations	in	
FN
NO
	concentrations	were	found	in	a	group	of	children	with	perennial	rhinitis	(Lundberg	
et	al.	1996).	Increased	FN
NO
	levels	have	been	described	in	upper	airway	infection	and	
nasal	 polyposis	 (Selimoglu	 2005).	However,	 according	 to	 Jorissen	 et	 al.	 (2001),	 the	
FN
NO
	 levels	 in	 people	 suffering	 from	 an	 upper	 airway	 infection	 did	 not	 differ	 from	
the	 levels	 of	 healthy	 individuals.	 In	 children	with	Kartagener	 syndrome	–	 a	 triad	of	
sinusitis,	bronchiectasis	and	situs	inversus	-	FN
NO
	levels	are	extremely	low	(Lundberg	
et	al.	1994).
2.5.2	Nasal	Lavage	Fluid	(NAL)
			The	nose	is	an	easily	accessible	part	of	the	human	airways	for	repeated	cytological	
and	immunological	assessments.	Most	of	the	inhaled	air	during	normal	breathing	enters	
via	 the	 nose	 and,	 therefore,	 the	 nasal	 mucosa	 serves	 as	 the	 primary	 barrier	 against	
inhaled	pollutants.	NAL	is	a	simple,	non-invasive	and	well	tolerated	method	to	assess	
inflammatory	changes	in	the	upper	airways	(Steerenberg	et	al.	1996).
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			Increased	levels	of	cytokines	in	NAL	have	been	detected	during	viral	infection	(Linden	
et	al.	1995),	in	allergic	diseases	(Hiltermann	et	al.	1997)	and	in	occupational	exposure	
(Hirvonen	et	al.	1999;	Roponen	et	al.	2001;	Purokivi	et	al.	2001).	Total	cell	count	(Blaski	
et	al.	1996)	and	differential	cell	count	of	inflammatory	cells	(Prat	et	al.	1993)	in	NAL	
can	be	reliably	used	in	the	investigation	of	upper	airway	inflammation.	In	addition	to	
cytokines,	other	inflammatory	mediators	such	as	EPO,	MPO	and	NO	can	be	measured	
from	nasal	lavage	fluid	(Noah	et	al.	1995;	Hirvonen	et	al.	1999;	Wlinder	et	al.	2001).
	 	 	Variation	 in	 cell	 counts,	NO	and	 cytokine	 levels	 of	NAL	has	 been	 evaluated	 and	
there	are	differences	between	 the	genders.	For	example,	baseline	cytokine	 levels	are	
significantly	 higher	 in	 males	 compared	 to	 females.	 However,	 the	 low	 intra-patient	
variability	makes	NAL	samplings	an	appropriate	method	 for	 assessing	upper	 airway	
inflammation	(Hauser	et	al.	1994;	Roponen	et	al.	2003).	
2.6	Lung	functions
			Spirometry	is	an	important	tool	for	a	lung	physician	in	clinical	work	since	the	spirometric	
values	change	in	several	lung	diseases.	For	example,	forced	expiratory	volume	in	one	
second	 (FEV1)	 is	often	decreased	 in	patients	with	asthma	or	COPD.	Lung	diffusion	
capacity	(DLCO)	is	decreased	in	parenchymal	lung	diseases	such	as	allergic	alveolitis	
(Erkinjuntti-Pekkanen	et	al.	1999).
			In	a	previous	study,	cytokine	and	NO	concentrations	in	NAL	were	increased	in	the	mould	
exposed	subjects	even	though	the	spirometric	values	remained	unaffected	(Roponen	et	
al.	2001).	In	a	Swedish	study,	no	significant	changes	in	FEV1	and	forced	vital	capacity	
(FVC)	were	found	in	subjects	exposed	to	indoor	air	microbes	of	a	moisture-damaged	
building	 (Gunnbjrnsdottir	et	al.	2003).	 	Conversely,	 reduced	FEV1	and	FVC	 levels	
have	 been	 reported	 in	 individuals	 exposed	 to	mould	 in	 indoor	 air	 at	 home	 (Kilburn	
2003).	Furthermore,	among	waste	collectors	exposed	to	various	bioaerosols,	the	FEV1	
decreased	significantly	on	the	fourth	day	after	a	vacation	(Heldal	et	al.	2003).
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3	AIMS	OF	THE	STUDY
	 The	overall	aim	of	this	study	was	to	assess	the	effects	of	experimental	Aspergillus 
fumigatus and	degraded	PVC	flooring	material	challenges	on	FE
NO
,	FN
NO
,	lung	functions,	
cytokines	 and	 NO	 in	 NAL.	 The	 reproducibility	 of	 FE
NO
	 and	 FN
NO
	 measurement	
techniques	was	also	studied.
The	specific	aims	of	the	study	were:
1.	 To	study	the	short-term	and	seasonal	reproducibility	of	FE
NO
	and	FN
NO
	in	healthy		
	 volunteers	(I).
2.	 To	assess	the	ability	of		experimental	Aspergillus fumigatus	challenge	to	cause		
	 inflammatory	changes	in	airways	as	assessed	by	FE
NO
,	FN
NO
,	lung	functions	and		
	 NO	in	NAL	and	self-reported	symptoms	(II).
3.	 To	assess	the	effects	of	experimental	A. fumigatus	inhalation	challenge	on		 	
	 cytokine	levels	(TNF-α,	IL-1β,	IL4-,	IL-6	and	IFN-γ)	in	NAL	in	subjects	with	or		
	 without	occupational	exposure	in	a	moisture-damaged	building	(III).
4.	 To	study	the	ability	of	experimental	PVC	flooring	material	challenge,		 	
	 simulating	low	concentrations	of	emissions	found	in	indoor	air	conditions,	to		
	 cause		airway	inflammation	as	assessed	by		FE
NO
,	FN
NO
,	lung	function	tests,		 	
	 cytokine	levels	in	NAL	as	well	as	the	symptoms	reported	by	the	subjects	(IV).	
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4	SUBJECTS	AND	METHODS
4.1	Subjects
	
4.1.1	Study	I
			To	assess	the	short	and	long-term	variations	of	FE
NO
	and	FN
NO
	twenty-one	healthy,	non-
smoking,	non-atopic	subjects	participated	voluntarily	in	the	study	(Table	1).	Twenty-
one	subjects	participated	in	the	study	in	the	autumn,	18	in	the	winter	and	17	during	the	
summer.	The	exclusion	criteria	are	described	in	Table	2.	Fasting	time	was	one	hour	prior	
to	the	exhalations	and	the	subjects	were	asked	to	avoid	nitrate-containing	foods	such	as	
lettuce	during	the	study	periods.
4.1.2	Studies	II-III
	 	 	Twenty-eight	subjects	volunteered	to	participate	in	study	II	where	the	effects	of	A. 
fumigatus	challenge	on	FE
NO
	and	FN
NO
	were	assessed.	All	 the	subjects	were	hospital	
personnel	and	they	were	working	in	two	different	hospital	buildings	in	Kuopio,	eastern	
Finland.	Moisture	 and	 mould	 problems	 in	 one	 of	 the	 buildings	 were	 confirmed	 by	
technical	and	microbiological	 investigations.	The	subjects	formed	3	groups.	Group	1	
consisted	of	13	subjects	working	in	a	moisture-damaged	building	(referred	in	text	as	a	
mould	exposed	group).	Group	2	consisted	of	5	atopic	non-asthmatic	subjects	without	
mould	exposure.	Group	3	was	a	control	group	including	10	non-atopic	non-asthmatic	
subjects	with	 no	 known	mould	 exposure.	The	 subject	 characteristics	 of	 study	 II	 are	
given	in	Table	1.	
			In	study	III,	in	which	the	effects	of	A. fumigatus challenge	on	cytokine	levels	were	
assessed,	the	subjects	were	the	same	as	those	in	the	study	II	but	one	atopic	male	subject	
was	 excluded	 as	 baseline	 cytokine	 levels	 in	 NAL	 are	 significantly	 higher	 in	 males	
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compared	 to	 females	 (Roponen	et	 al.	 2003).	Thus,	 all	 the	 subjects	 in	 study	 III	were	
females	(Table	1).	
Exclusion	criteria	in	studies	II-III	are	given	in	Table	2.
4.1.3	Study	IV
			In	this	study	there	were	10	volunteer	subjects	with	occupational	PVC	exposure	who	
were	 challenged	with	degraded	PVC	material	 under	 controlled	 conditions	 (Table	1).	
Five	subjects	had	been	diagnosed	with	asthma	and	three	of	these	cases	were	diagnosed	
in	the	period	during	which	they	were	exposed	to	degrading	PVC	flooring	material	at	the	
workplace.	The	five	non-asthmatic	subjects	had	a	variety	of	symptoms	(upper	and	lower	
respiratory	tract	symptoms,	conjunctival	irritation	and	eczema).	The	exclusion	criteria	
are	shown	in	Table	2.	The	subjects	were	asked	not	to	use	inhaled	steroids,	long-acting	
β
2
-adrenoreceptor	 agonists,	 leukotriene	 receptor	 antagonists	 and	mast	 cell	 stabilizers	
for	 three	 days	 before	 the	 challenges	 and	 short-acting	β
2
-adrenoreceptor	 agonists	 for	
six	hours	before	the	challenges.	All	of	the	subjects	worked	in	a	building	where	the	first	
indoor	air	evaluations	were	made	in	1997	and	later	the	cause	of	the	symptoms	in	the	
occupants	was	related	to	PVC	flooring	materials	as	described	earlier	(Tuomainen	et	al.	
2004).
4.2	Methods
4.2.1	Analysis	of	FE
NO
	and	FN
NO
	(I,	II,	IV)
			FE
NO
	was	measured	by	chemiluminescence	analyser	(Sievers	Model	280	NOA,	Sievers	
Instruments	 INC.,	Boulder,	CO,	USA)	according	 to	ERS	and	ATS	recommendations	
(Kharitonov	et	al.	1997;	ATS	1999)	using	the	same	protocol	described	earlier	(Purokivi	
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et	 al.	 2000;	 Figure	 2).	When	 measuring	 FE
NO
,	 the	 subjects	 performed	 a	 slow	 vital	
capacity	maneuver	 for	 30	 s	 against	 a	 fixed	 expiratory	 resistance.	The	pressure	 level	
during	exhalation	was	optimized	by	following	the	computer	screen	on-line	to	reach	a	
constant	50	mLs־	flow	rate.	Exhaled	air	was	led	through	a	nonrebreathing	valve	into	a	
Teflon	tubing	system	connected	to	the	analyser.	The	relative	standard	deviation	between	
the	three	exhaled	samples	was	permitted	to	be	<	10	%	and	the	detection	limit	for	NO	
was	1	part	per	billion	(ppb).	The	measurements	were	performed	in	the	same	laboratory	
under	 constant	 conditions.	The	 chemiluminescence	 analyzer	was	 calibrated	 daily	 by	
using	zero	air	and	a	certified	concentration	of	NO.
			FN
NO
	levels	were	measured	by	an	application	of	the	fixed	flow	exhalation	technique	
(Silkoff	et	al.	1999).	Two	soft,	well-fitting	nose	pieces	were	placed	at	the	entrance	of	
both	nostrils.	The	pieces	were	attached	via	a	”Y”	connector	to	a	two-way	valve	and	a	
resistor	was	placed	in	the	exhalation	limb,	which	required	a	pressure	of	10	cm	H
2
O	to	
produce	a	flow	of	100	mL/minute.	The	subjects	inhaled	normal	room	temperature	air	to	
total	lung	capacity	(TLC)	via	their	mouths	and	exhaled	nasally	while	targeting	a	flow	
signal	displayed	on	a	computer	monitor.	The	expiration	was	continued	until	a	steady	NO	
plateau	lasting	at	least	10	seconds	was	reached.	The	contribution	of	the	oral	NO	was	
excluded.	The	measurement	was	repeated	3	times	and	the	mean	value	was	calculated.
4.2.2	Nasal	Lavage	(II,	III,	IV)
			Nasal	lavage	samples	were	gathered	according	to	the	protocol	described	previously	by	
Hirvonen	et	al.	(1999)	with	some	modifications.	Prewarmed	(+37°C)	Hanks’	balanced	
salt	 solution	 (4.5	ml)	 was	 instilled	 through	 a	 heat-softened	 catheter	 into	 the	 nostril	
(Figure	3).	The	subject	held	his	or	her	chin	down	during	the	instillation,	and	held	the	
catheter	in	place	by	pinching	the	nostrils	closed.	The	cartilaginous	bridge	of	the	nose	
was	 vibrated	 by	 using	 a	 neonatal	 percussor	 (Neo-Cussor™,	 General	 Physiotherapy	
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Inc.,	St.	Louis,	MO)	while	the	fluid	was	refluxed	three	times.	The	same	protocol	was	
repeated	on	the	opposite	nostril.	The	sample	was	centrifuged	(425	x	g,	10	min)	and	the	
cells	were	resuspended	in	2	ml	of	the	supernatant.	The	remaining	cell	suspension	was	
incubated	for	24	h	at	37°C	and	then	centrifuged	(425	x	g,	10	min).	The	supernatant	and	
cells	were	frozen	at	–70°C.
	 	 	 In	 studies	 II	 and	 III,	NAL	 samples	 for	measurement	 of	 cytokines	were	 collected	
immediately	before	both	A. fumigatus and	placebo	challenges	and	exactly	at	6	and	24	
hours	after	A. fumigatus and	placebo	challenges	(Table	2).	In	study	IV,	NAL	samplings	
were	performed	immediately	before	and	after	the	PVC	and	control	challenges	(Table	
3).
4.2.3	Analysis	of	Cytokines	and	NO	in	NAL	(III,	IV)
	 	 	 Concentrations	 of	 IFN-γ	 (III),	 TNF-α	 (III,	 IV),	 IL-1β	 (III),	 IL-4	 (III,	 IV),	 IL-6	
(III,	 IV)	and	IL-12	(IV)	 in	 the	NAL	supernatant	were	analyzed	by	using	ELISA	kits	
(R&D	Systems™,	Minneapolis,	MN,	USA).	Assays	were	 analyzed	 according	 to	 the	
manufacturer's	 instructions	with	 the	ELISA	microplate	 reader	 (iEMS	Reader	MF™,	
Labsystems,	 Finland)	 at	 a	wavelength	 of	 450	 nm	 by	 comparing	 the	 absorbances	 of	
the	 samples	 to	 the	 standard	 curve.	 Each	 standard	 and	 sample	was	 run	 in	 duplicate.	
Extrapolated	values	below	lowest	standard	points	(IFN-γ,	31.3	pg/ml,	TNF-α,	31.3	pg/
ml;	IL-1β,	15.6	pg/ml;	IL-4,	8.2	pg/ml;	IL-6,	15.6	pg/ml;	IL-12,	8	pg/ml)	were	used	as	
such	instead	of	replacing	them	with	a	constant.	NO	in	the	NAL	supernatant	was	assayed	
by	the	Griess	reaction	as	the	stable	NO	oxidation	product	nitrite	(Green	et	al.	1982)	as	
described	in	detailed	elsewhere	(Hirvonen	et	al.	1999).	Cytokines	and	NO	in	NAL	were	
analyzed	from	incubated	supernatants.
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Table	1.	Subject	characteristics	in	studies	I-IV.
	 I	 II	 III	 IV
_____________________________________________________________________
Number	of	subjects:	 21	 28	 27	 10
Age	years:	 38	 45	 45	 43
(range)	 (22-57)	 (27-60)	 (27-60)	 (28-53)
Gender:
Female	 14	 27	 27	 3
Male	 7	 1	 0	 7
Smoking:
Current	smokers	 0	 1	 1	 2
Ex-smokers	 0	 4	 4	 2
Positive	Skin	Prick	
Tests:
Basic	series	or	
Storage	mites	 	 10	 9
Moulds	 	 1#	 1#
Doctor-diagnosed
asthma:	 0	 0	 0	 5
Occupational	mould	 	 13	 13
exposure:
Occupational	PVC	 	 	 	 10
exposure:
_____________________________________________________________________
#Geotrichium	candidum
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Table	2.	Exclusion	criteria	in	studies	I-IV
	 I	 II-III	 IV
Criterion
_____________________________________________________________________
Smoking	 All	the	subjects	 Prohibited	during	 Prohibited	during
	 non-smokers	 the	study	period	 the	study	period
Vigorous	Exercise	 Prohibited	during	 Prohibited	during	 Prohibited	during
	 the	study	period	 the	study	period	 the	study	period
Occurrence	of	 at	least	6	weeks	 at	least	6	weeks	 at	least	6	weeks	
previous	respiratory	 prior	to	the	study	 prior	to	the	study	 prior	to	the	study
tract	infection
Regular	medication	 Prohibited	 Prohibited	 Prohibited	3	days
	 	 	 before	the	study
Short-acting	β
2
-agonists	 Prohibited	during	 Prohibited	during		 Prohibited	6	hours
	 the	study	period	 the	study	period	 before	the	study
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Table	3.	Protocols	of	studies	II-III	(A)	and		study	IV	(B).
A.
Time	 	 Protocol
Before	the	exposure		 Exhaled	and	nasal	NO
	 	 Lung	functions	(spirometry,	diffusion	capacity,	PEF)
	 	 Cytokines	and	NO	in	NAL
During	the	exposure		 Lung	functions	(FEV1,	PEF)
	 	 Self-reported	symptoms
Next	morning	after	the	exposure	 Self-reported	symptoms
3	hours	after	the	exposure	 Exhaled	and	nasal	NO
	 	 PEF
6	hours	after	the	exposure	 Exhaled	and	nasal	NO
	 	 Cytokines	and	NO	in	NAL
	 	 PEF
24	hours	after	the	exposure	 Exhaled	and	nasal	NO
	 	 Lung	functions	(spirometry,	diffusion	capacity,	PEF)
	 	 Cytokines	and	NO	in	NAL
	 	 Self-reported	symptoms
B.
Time	 Protocol
Before	the	exposure	 Exhaled	and	nasal	NO
	 Lung	functions	(spirometry	and	PEF)
	 Cytokines	and	NO	in	NAL
Exposure	(4	h)	 Self-reported	symptoms
	 PEF	at	1	h	intervals
	 Exhaled	breath	sample	(at	2	hours	after	PVC	exposure)
	 VOC	collection	from	the	chamber	air	(sampling	time	2	h)
Immediately	after	 Exhaled	and	nasal	NO
the	exposure	 Lung	functions	(spirometry	and	PEF)
	 Cytokines	and	NO	in	NAL
2	h	after	the	exposure	 Exhaled	and	nasal	NO
	 Lung	functions	(spirometry	and	PEF)
Next	morning	after	 Self-reported	symptoms
the	exposure	 Exhaled	and	nasal	NO
	 Lung	functions	(spirometry	and	PEF)
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Figure 3. Collection of a NAL sample.
Figure 2. Performance of  FE
NO
 measurement.
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4.2.4	Analysis	of	protein	and	2-ethylhexanol	in	NAL	(IV)
			Part	of	the	NAL	was	centrifuged	at	1800	rpm	(10	min),	after	which	200	µl	was	separated	
into	an	Eppendorf	 tube	for	 the	protein	measurement	and	it,	as	well	as	 the	rest	of	 the	
supernatant	were	stored	at	-18	°C	before	the	analysis	of	proteins	and	2-ethylhexanol.	The	
protein	content	of	the	samples	was	measured	with	the	Bradford	method	in	a	microplate	
(Bradford	1976).	Further,	2-ethylhexanol	of	the	NAL	was	extracted	with	ethyl	acetate	
and	analyzed	by	gas	chromatography	and	mass	spectrometry.
4.2.5	Lung	Function	Tests	(II,	IV)
	 	 	 The	 standard	 spirometric	 values	 (Custo	 Med	 GmbhTM,	 Munich,	 Germany)	 and	
pulmonary	diffusion	capacity	(Type	2200	Sensor	Medics	BV™,	Bilthoven,	Netherlands)	
were	measured	according	 to	American	Thoracic	Society	guidelines	 (ATS	1995;	ATS	
1996).	Reference	values	of	Viljanen	et	al.	(1982)	for	the	Finnish	population	were	used.	
Peak	expiratory	flow	(PEF,	Mini	Wright	Standard	Peak	Flow	Meter,	Clement	Clarke	
International	Ltd.,	Edinburgh,	UK)	values	were	followed	during	and	after	the	challenges	
in	studies	II	and	IV.
4.2.6	Skin	Prick	Tests	(II,	III)
			Atopic	status	was	examined	by	ALK	skin	prick	tests	(ALK	laboratories®,	Copenhagen,	
Denmark).	The	prick	 tests	 included	14	common	environmental	 allergens	 (two	house	
dust	mites	 (Dermatophagoides farinae and Dermatophagoides pteronyssinus),	 birch,	
alder,	meadow	 fescue,	 timothy,	meadow	grass,	mugwort,	 dandelion,	 horse,	 dog,	 cat,	
cow	 and	 natural	 rubber),	 three	 storage	mites	 (Lepidoglyphus destructor, Acarus siro 
and	 Tyrophagus putrescentiae) and	 13	 moulds	 (Alternaria alternata, Cladosporium 
herbarum, Aspergillus fumigatus, Aspergillus versicolor, Aureobasidium pullulans, 
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Botrytis cinerea, Chaetomium globusum, Geotrichium candidum, Mucor racemosus, 
Penicillium brevicompactum, Penicillium expansum, Phoma herbarum and	Trichoderma 
viride).	ALK	allergen	diluents	and	histamine	hydrochloride	(10	mg/mL)	were	used	as	
negative	and	positive	controls,	respectively.	If	there	was	at	least	one	positive	reaction	
with	a	diameter	3	mm	or	more	then	the	atopy	was	defined.
4.2.7	Symptoms	Related	To	Challenges	(II,	IV)
			During	the	challenges	(Aspergillus fumigatus	vs.	placebo	in	study	II,	PVC	vs.	ceramic	
tile	in	study	IV)	the	subjects	were	asked	to	report	if	they	experienced	any	symptoms.	In	
addition,	they	reported	any	possible	symptoms	which	occurred	on	the	next	morning	after	
the	challenge.	The	subjects	wrote	down	the	symptoms	in	the	PEF	follow-up	form.
4.2.8	Cytospin	(III,	IV)
			Cytocentrifuge	preparations	were	made	by	using	100	µl	of	resuspended	cell	suspension,	
in	which	the	mucus	was	broken	by	0.5	%	dithiothreitol/0.1	%	bovine	serum	albumin.	
The	solution	was	centrifuged	and	the	slides	were	stained	with	May-Grunwald-Giemsa	
staining	(Prat	et	al.	1993)	for	the	cell	differential	counts.	The	standard	was	to	count	100	
cells	per	a	sample.	The	cell	differential	counts	were	collected	before	and	at	6	and	24	
hours	after	the	challenges	(A. fumigatus	vs.	placebo,	PVC	vs.	control).
4.2.9	IgE	and	ECP	analysis	(II)
	 	 	 From	 serum	 samples,	 total	 IgE	 (IU/L)	 was	 determined	 by	 EIA	 (Immulite	 total	
IgE®,	 Diagnostic	 Products	 Corporation,	 Los	 Angeles,	 CA,	 USA),	 ECP	 (IU/L)	 by	
radioimmunoassay	 (RIA®,	 Pharmacia	 et	Upjohn,	Uppsala,	 Sweden),	 and	Aspergillus 
fumigatus	IgE	(IU/L)	by	UniCAP-FEIA	(Model	Unicap	100®,	Pharmacia	AB,	Uppsala,	
Sweden).
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4.2.10	Statistical	Methods
			Study	I:	Means	and	standard	deviations	(SD)	were	used	to	describe	the	NO	data.	Day-
to-day	and	week-to-week	reproducibility	were	visualised	by	using	Bland-Altman	plots	
(Bland	and	Altman	1986).	Intraday,	day-to-day,	week-to-week	and	seasonal	variations	
of	FE
NO
	and	FN
NO
	as	well	as	the	correlation	between	FE
NO
	and	FN
NO
	were	examined	
by	intra-class	correlation	analysis	(ICC).	ICC-values	>	0.6	were	considered	clinically	
significant	 (Faul	 et	 al.	 1999).	 The	 coefficients	 of	 variation	were	 also	 calculated.	 In	
addition,	 intraday	 changes	 of	 FE
NO
	 and	 FN
NO
	 were	 studied	 by	 variance	 analysis	 of	
repeated	measures.
			Study	II:	Differences	in	changes	from	baseline	on	the	course	of	time	(e.g.	FE
NO
,	FN
NO
,	
NO	in	NAL	and	lung	functions)	between	the	A. fumigatus and	placebo	exposures	were	
compared	by	variance	analysis	for	repeated	measures.	In	addition	to	variance	analysis,	
the	change	in	NO	levels	was	calculated	as	NO	concentration	[6	or	24	hours	after	the	
challenge]	-	NO	concentration	[baseline	before	the	challenge]	for	both	A. fumigatus	and	
placebo	challenges	and	Wilcoxon	signed	 rank	 test	was	used	 to	compare	 the	changes	
between	active	agent	and	placebo	inhalations.	Logarithmic	transformations	were	used	
for	 variables	 not	 normally	 distributed.	 Means	 between	 the	 groups	 were	 compared	
by	one-way	ANOVA	and	mean	 ranks	by	Kruskall-Wallis	 test.	The	percentages	were	
compared	by	using	chi-square	test.
			Study	III:	The	change	in	cytokine	production	was	calculated	as	cytokine	concentration	
[6	or	24	hours	after	the	challenge]	-	cytokine	concentration	[baseline	before	the	challenge]	
for	 both	A. fumigatus	 and	 placebo	 challenges.	Despite	 standard	 transformations,	 the	
normal	distribution	of	the	cytokine	data	was	not	achieved.	Therefore,	the	non-parametric	
Wilcoxon	 signed	 rank	 test	was	used	 to	 compare	 the	 changes	of	 cytokine	production	
between	the	challenges	(A. fumigatus	vs.	placebo)	at	different	time	points	(before	the	
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challenges,	 6	 and	 24	 hours	 after	 the	 challenge).	 Mean	 ranks	 between	 groups	 were	
compared	by	Kruskall-Wallis	test.
			Study	IV:	The	changes	in	different	parameters	during	and	after	the	exposures	were	
studied	by	variance	analysis	of	repeated	measures	(e.g.	FE
NO
,	FN
NO
,	NO	and	cytokines	
in	NAL	and	lung	functions).	Logarithmic	transformations	were	performed	for	data	not	
normally	distributed.	In	addition,	induced	cytokine	responses	were	calculated	as	cytokine	
concentration	[immediately	after	the	challenge]	-	cytokine	concentration	[baseline	before	
the	challenge]	for	both	PVC	and	control	tests	and	Wilcoxon	signed	rank	test	was	used	
to	compare	the	changes	between	the	tests.	Between	groups	differences	were	analyzed	
by	the	Fisher’s	exact	test.	The	Pearson’s	test	was	used	to	determine	correlations.	The	
percentages	were	compared	by	using	the	Chi-square	test.
			In	all	of	the	studies	the	data	was	analysed	by	SPSS	for	Windows	11.5	(SPSS	Inc.™,	
Chicago,	USA)	and	p-values	<	0.05	were	considered	to	be	statistically	significant.
4.3	Study	Protocols
4.3.1	Study	I
			FE
NO
	and	FN
NO
	measurements	were	performed	in	three	periods:	the	first	in	the	autumn,	
the	second	in	winter	and	the	third	in	summer.	During	the	first	study	day	of	the	autumn	
period,	the	FE
NO
	and	FN
NO
	values	were	measured	in	the	morning	(at	7	to	9	o’clock)	and	
again	six	hours	later	in	the	afternoon	(at	13	to	15	o’clock).	In	the	autumn	period,	both	
the	morning	and	afternoon	measurements	of	the	FE
NO
	and	FN
NO
	were	repeated	24	hours	
and	seven	days	after	the	first	measurement	day.	In	the	winter	and	summer,	the	FE
NO
	and	
FN
NO
	measurements	were	performed	on	one	day	in	the	morning	(at	7	to	9	o’clock).
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4.3.2	Studies	II	and	III	(Table	3A)
	 	 	Each	 subject	 underwent	 randomly	 two	 challenges	where	 they	 inhaled	Aspergillus 
fumigatus	or	placebo	solution	via	a	nebulizer	(Spira	elektro	2	flowmeter™,	Respiratory	
Care	Center,	Hmeenlinna,	Finland)	 using	 an	oronasal	mask.	The	 inhalation	 aerosol	
was	generated	from	a	1-mL	sample	reservoir	with	the	nebulizing	pressure	adjusted	to	
2	bar	(flow	rate	7.5	mL/min).	The	nebulization	time	was	0.4	s,	equivalent	to	a	mean	
volume	uptake	of	6.5+/-0.3	µL	(SD)	of	 the	solution	per	breath.	The	subjects	 inhaled	
each	 solution	 60	 times	 using	 controlled	 tidal	 volume	 respiration	 during	 a	 period	 of	
approximately	5	min	and	this	was	followed	by	a	rest	period	of	5	min	and	subsequent	
spirometric	measurements.
			FEV1	was	measured	in	triplicate	before	the	challenges,	and	the	greatest	value	was	used	
as	 the	baseline.	Four	series	of	10-fold	dilutions	of	commercial	A. fumigatus allergen	
(ALK-ABELLO®,	Madrid,	Spain)	were	prepared	immediately	before	the	challenges	and	
the	inhalation	was	started	with	the	lowest	dilution.	A. fumigatus	solution	was	a	purified	
allergen	product	approved	to	be	marketed	in	Finland	by	National	Agency	for	Medicine.	
The	 subjects	 inhaled	 the	allergen	dilution	 from	a	concentration	of	0.01	mg/mL	until	
the	maximal	concentration	of	10	mg/mL	was	administered.	FEV1	was	measured	5	min	
after	each	inhaled	concentration.	The	difference	between	the	baseline	and	lowest	FEV1	
was	observed.	The	allergen	diluent	(physiological	salt	solution)	was	used	as	placebo.	
The	 placebo	 challenge	 protocol	was	 identical	 to	 the	A. fumigatus challenge	 but	 the	
concentration	of	the	solution	did	not	change	during	the	challenge.	The	challenges	were	
performed	one	week	apart	at	the	same	time	of	the	day.
			In	study	II,	FE
NO
	and	FN
NO
	were	measured	before	the	challenges	and	at	3,	6	and	24	
hours	after	 the	challenges.	 In	addition	 to	FEV1	follow-up	during	 the	challenges,	 the	
lung	functions	(spirometry,	diffusion	capacity)	were	assessed	before	the	challenges	and	
at	24	hours	after	them	in	study	II.
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	 	 	 In	study	III,	 the	NAL	samplings	for	cytokine	(IFN-γ,	TNF-α,	 IL-1β,	 IL-4	and	IL-
6)	 and	cell	differential	 count	 assessments	were	performed	before	 the	challenges	and	
subsequently	at	6	and	24	hours	later.
4.3.3	Study	IV
			The	exposure	chamber	(volume	1.2	x	1.2	x	2.2	m)	was	constructed	of	stainless	steel.	
It	was	equipped	with	a	small	window	and	had	separate	adjustable	ventilation	(Figure	
4).	The	ventilation	was	adjusted	 so	 that	 the	carbon	dioxide	concentration	during	 the	
exposure	 session	 in	 the	 chamber	 stayed	 below	 1000	 ppm.	 The	 chamber	 was	 tested	
to	ensure	it	was	tight	and	clean	(total	volatile	organic	compounds	(TVOC)	below	10	
µg/m3).	The	exposure	material	used	in	the	exposure	tests	 in	the	chamber	was	a	PVC	
flooring	material	 recently	 removed	 from	an	office	where	 the	occupants	had	 suffered	
respiratory	and	dermal	irritation	symptoms	related	to	degrading	PVC.	The	area	of	this	
Figure 4. The exposure chamber used in degraded PVC material challenge study.
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PVC	material	placed	in	the	chamber	was	1	m2,	with	a	new	piece	of	PVC	being	replaced	
every	week.	During	the	control	tests,	unused	ceramic	tiles	(area	1	m2)	were	placed	in	the	
chamber	floor.	TVOC	and	2-ethylhexanol	concentrations	were	measured	during	every	
PVC	exposure	test	in	the	chamber	air	(Tuomainen	et	al.	2004).	
			Volatile	organic	compounds	from	the	chamber	air	and	from	the	exhaled	breath	were	
collected	and	analyzed	two	hours	after	the	beginning	of	the	exposure	in	laminate	bags	
according	to	 the	method	described	by	Tuomainen	et	al.	 (2001).	For	example,	similar	
laminate	 bags	 have	 been	 used	 in	 collecting	 air	 samples	 such	 as	 sulphur	 oxides	 and	
the	 bags	 do	 not	 release	 any	 emissions	 themselves.	 In	 the	 chamber,	 the	 sample	was	
always	collected	near	to	the	breathing	zone	of	the	test	subject.	Levels	of	TVOC	and	2-
ethylhexanol	were	measured	from	the	samples.
			The	protocol	of	the	chamber	challenge	tests	for	the	subjects	is	shown	in	Table	3B.	The	
challenges	lasted	4	hours	and	the	interval	between	the	two	exposures	ranged	from	three	
to	seven	weeks.	PVC	and	control	exposures	were	performed	in	a	random	order	and	the	
subjects	were	blinded	to	the	type	of	exposure.
	4.4	Ethics
			The	studies	I,	II	and	III	were	approved	by	the	Ethics	Committee	of	Kuopio	University	
Hospital	and	 the	study	 IV	by	 the	Ethics	Committee	of	Helsinki	University	Hospital.	
All	of	the	studies	were	performed	according	to	principles	of	the	Helsinki	Declaration	
(World	Medical	Association	2004).	All	the	subjects	were	asked	a	written	approval	for	
the	participation	in	the	studies.
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5.	RESULTS
5.1	Short	and	long-term	reproducibility	of	FE
NO
	and	FN
NO
	levels	(I)
	 	 	In	all	the	measurements,	the	levels	of	FN
NO
	were	lower	in	the	morning	than	in	the	
afternoon.	 In	 the	 autumn,	 the	 afternoon	 values	 of	 FN
NO
	 were	 significantly	 higher	
compared	to	those	taken	in	the	morning	(p=0.003)	and	the	correlation	between	morning	
and	afternoon	levels	was	not	clinically	significant	(r=0.565,	Table	4A).	The	day-to-day	
correlation	of	FN
NO
	 levels	was	 significant	 in	 the	mornings	but	 not	 in	 the	 afternoons	
(r=0.868,	r=0.543,	respectively,	Table	4B,	Figure	5A).
	 	 	 In	 line	with	FN
NO
,	 the	mean	 levels	of	FE
NO
	were	 regularly	 lower	 in	 the	mornings	
compared	to	the	afternoon	values	of	the	same	day.	There	was	a	significant	difference	
between	the	morning	and	afternoon	values	in	the	autumn	(p<0.001)	and	there	was	also	
a	clinically	significant	correlation	between	the	values	(r=0.830,	Table	4A).	Day-to-day	
correlation	of	FE
NO
	was	clinically	 significant	when	measured	24	hours	apart	both	 in	
the	mornings	and	the	afternoons	(r=0.784,	r=0.779,	respectively,	Table	4B,	Figure	5B).	
In	addition,	 the	week-to-week	correlation	of	FN
NO
	was	clinically	significant	 for	both	
morning	and	afternoon	values	(r=0.637,	r=0.781,	respectively,	Table	4C,	Figure	6A).	
With	 the	 seven	 days	 interval,	 the	 correlation	 between	 FE
NO
	measurements	was	 also	
high	in	the	mornings	(r=0.738,	Table	4C,	Figure	6B).	When	comparing	the	afternoon	
week-to-week	values	of	the	FE
NO
	measurements,	no	clinical	significance	was	reached	
(r=0.560,	Table	4C).
			Seasonal	variations	of	both	FE
NO	
and	FN
NO
	were	low,	and	the	correlations	were	clinically	
significant	(r=0.709,	r=0.624,	respectively,	Table	4D).	FE
NO
	levels	were	clearly	lower	
than	 the	FN
NO
	 levels	and	 they	did	not	correlate	with	each	other	at	any	measurement	
point	(data	not	shown).	
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Table	4.	Short-term	and	Seasonal	Variations	of	FN
NO
	and	FE
NO
	studied	by	intra-
class	correlation	analysis	(ICC)	and	coefficients	of	variation	(CoV)	(I).
A.	 Intraday	 variation	 of	 FN
NO
	 and	 FE
NO
	 (ppb)	 during	 three	 days	 in	 autumn	
(mean±SD)
FN
NO
	 Mornings	 Afternoons	 n	 r	 p	 CoV	(%)
	 127.1±28.9	 149.2±40.2	 54	 0.565	 0.005	 11.0
FE
NO
	 Mornings	 Afternoons	 n	 r	 p	 CoV	(%)
	 14.8±5.8	 17.4±6.0	 54	 0.830	 0.000	 13.7
B.	Day-to-day	variation	of	FN
NO
	and	FE
NO
	(ppb)	during	the	first	week	in	autumn	
(mean±SD).
FN
NO
	 1st	day	 2nd	day	 n	 r	 p	 CoV	(%)
Morning	 121.4±37.5	 119.8±29.6	 21	 0.868	 0.000	 8.1
Afternoon	 136.0±51.5	 144.2±45.0	 21	 0.543	 0.004	 17.5
FE
NO
	 1st	day	 2nd	day	 n	 r	 p	 CoV	(%)
Morning	 14.6±6.7	 14.2±5.1	 21	 0.784	 0.000	 16.1
Afternoon	 16.7±7.2	 16.8±5.6	 21	 0.779	 0.000	 14.7
C.	Week-to-week	 variation	 of	 FN
NO
	 and	 FE
NO
	 (ppb)	 during	 the	 autumn	 period	
(mean±SD).
FN
NO
	 1st	week	 2nd	week	 n	 r	 p	 CoV	(%)
Morning	 121.4±37.5	 128.0±32.1	 18	 0.637	 0.001	 12.3
Afternoon	 136.0±51.5	 151.4±48.1	 18	 0.781	 0.000	 12.4
FE
NO
	 1st	week	 2nd	week	 n	 r	 p	 CoV	(%)
Morning	 14.6±6.7	 15.4±7.3	 18	 0.738	 0.000	 19.4
Afternoon	 16.7±7.2	 19.4±8.5	 18	 0.560	 0.005	 17.0
D.	 Seasonal	 variation	 of	 FN
NO
	 and	 FE
NO
	 (ppb)	 in	 autumn,	winter	 and	 summer	
mornings	(mean±SD).
	 autumn	 winter	 summer	 n	 r	 p	 CoV	(%)
FN
NO
	 121.4±37.5	 133.5±29.7	 138.1±47.6	 17	 0.624	 0.000	 21.0
FE
NO
	 14.6±7.2	 16.6±6.4	 17.4±8.0	 17	 0.709	 0.000	 15.7
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Figure 5. Repeatability of FN
NO
 (A) and FE
NO
 (B) measurements performed in consecutive 
mornings 24h apart visulized by Bland-Altman plots. It is anticipated that 95% of the 
differences between measures will be < 2 SD.
Figure 6. Repeatability of FN
NO
 (A) and FN
NO
 (B) measurements collected one week 
apart in the mornings expressed by Bland-Altman plots. It is anticipated that 95% of the 
differences between measures will be <2 SD.
Figure	5A Figure	5B
Figure	6A Figure	6B
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5.2	The	induced	effects	of	Aspergillus fumigatus	challenge	(II,	III)
5.2.1	Symptoms	related	to	the	challenge
	 	 	On	the	next	morning	after	 the	challenges,	 the	subjects	 reported	significantly	more	
frequently	 airway	 symptoms	 after	 the	 A. fumigatus challenge	 compared	 to	 placebo	
inhalation	 (57	%	 vs.	 25	%,	 respectively,	 p=0.014,	 n=27).	 Symptoms	 of	 both	 upper	
(blocked	nose,	 rhinorrhea,	 sneezing)	 and	 lower	 (cough,	 phlegm)	 airways	were	more	
common	 during	 the	A. fumigatus	 challenge	 compared	 to	 placebo	 inhalation	 but	 the	
differences	were	not	statistically	significant	(data	not	shown).
5.2.2	FENO 	and	FNNO 	levels
			The	baseline	levels	of	FE
NO
	prior	to	the	A. fumigatus and	placebo	inhalations	(20.4	ppb	
and	21.7	ppb,	respectively)	did	not	differ	significantly.	A	significant	increase	in	FE
NO
	
levels	of	all	the	subjects	was	observed	after	the	A. fumigatus	inhalation	(p=0.002)	and	
the	highest	FE
NO
	values	were	achieved	three	hours	after	the	A. fumigatus inhalation.	No	
such	responses	were	detected	after	the	placebo	inhalation	and	there	was	a	significant	
difference	 between	 the	 mould	 and	 placebo	 challenges	 (p<0.05)	 (Figure	 7A).	 The	
difference	was	not	dependent	on	the	group	to	which	the	subjects	belonged.	In	statistical	
analysis,	the	atopy	was	not	related	to	changes	in	FE
NO
	levels.	When	one	subject	who	
experienced	an	asthmatic	reaction	during	the	A. fumigatus challenge	(25	%	decrease	in	
FEV1)	was	excluded,	there	was	still	a	tendency	but	not	a	significant	difference	in	FE
NO
	
levels	between	the	challenges	(p=0.082).
			The	baseline	levels	of	FN
NO
	did	not	differ	significantly	between	the	A. fumigatus and	
placebo	challenges	(129.5	ppb	and	127.0	ppb,	respectively).	During	the	24	hour	follow-
up	after	the	challenges,	the	levels	FN
NO
	of	all	the	subjects	increased	significantly	after	
the placebo	inhalation	(p=0.003)	and	a	similar	tendency	was	seen	after	the	A. fumigatus 
challenge	(p=0.051).	The	peak	levels	of	FN
NO
	after	both	challenges	were	measured	six	
hours	after	the	inhalations.	The	FN
NO
	profiles	after	the	challenges	were	almost	identical	
(p=0.81)	(Figure	7B).
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5.2.3	Lung	functions
			The	baseline	FVC	(3.37	l,	4.16	and	3.44,	respectively,	p=0.046)	and	FEV1	(2.78	l,	
3.56	l	and	3.44	l,	respectively,	p=0.004)	were	significantly	lower	among	the	subjects	
with	occupational	mould	exposure,	compared	to	atopic	and	control	groups.	The	baseline	
pulmonary	diffusion	capacities	were	significantly	higher	among	the	atopic	individuals	
compared	to	subjects	in	the	mould	exposed	and	control	groups	(11.9	mmol/min/kPA,	
8.7,	9.3,	respectively,	p=0.033).
	 	 	 FEV1	 decreased	 significantly	 during	 the	A. fumigatus	 (3.04-2.94	 l,	 p=0.013)	 and	
placebo	 (3.03-2.98	 l,	p=0.029)	challenges.	There	was	also	a	significant	difference	 in	
FEV1	changes	between	the	challenges	(p=0.049)	but	the	changes	were	not	dependent	
on	the	group.	However,	there	was	one	subject	who	exhibited	a	decrease	of	25	%	in	FEV1	
after	A. fumigatus challenge	and	a	12	%	decrease	after	placebo	inhalation.	When	this	
subject	was	excluded,	the	difference	in	changes	of	FEV1	between	the	inhalations	did	not	
reach	a	statistically	significant	level	(p=0.320).	There	were	no	significant	differences	in	
spirometric	values	or	in	diffusion	capacity	between	A. fumigatus and	placebo	inhalations	
at	24	hours	after	the	challenges.	In	addition,	PEF-levels	were	similar	in	both	groups	and	
they	did	not	change	significantly	after	A. fumigatus	or	placebo	challenges.
Figure 7. The changes in mean levels of a) FE
NO
 (all of the subjects) and b) FN
NO
 
after A. fumigatus (—) and placebo (…) challenges (measured before and at 3, 6 and 
24 hours later). There was a significant difference between the challenges in FE
NO
 
(p<0.05), but not in FN
NO
.
Figure	7A Figure	7B
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5.2.4	NO	and	Cytokines	in	NAL
			There	was	an	increase	in	NO	levels,	assessed	as	the	nitrite	concentration	in	NAL,	at	six	
hours	after	the	A. fumigatus	challenge	but	differences	were	not	statistically	significant	
when	compared	to	placebo	(data	not	shown).
	 	 	The	mean	values	of	TNF-α,	 IL-1β,	 IL-4,	 IL-6	and	 IFN-γ	 in	NAL	before	 the	 first	
challenge	are	given	in	Table	5.	Before	the	challenges,	the	lowest	mean	levels	of	TNF-
α,	IL-1	β	and	IL-4	were	detected	among	mould	exposed	subjects	and	IL-6	as	well	as	
IFN-γ	among	the	atopic	subjects.	The	highest	basal	concentrations	of	all	the	cytokines	
were	measured	in	the	samples	of	the	control	subjects.	The	only	statistically	significant	
difference	between	the	groups	was	detected	in	TNF-α	levels	(p=0.029).
	 	 	Mean	 levels	 of	 IL-1β	 in	NAL	 increased	 time-dependently	 after	 the	A. fumigatus	
challenge	with	the	peak	concentrations	being	achieved	24	hours	after	the	challenge.	In	
contrast,	IL-1β	levels	decreased	after	the	placebo	challenge	compared	to	the	baseline.	
When	 all	 the	 subjects	 were	 examined	 as	 a	 single	 group,	 the	 changes	 of	 the	 IL-1β	
levels	 from	 the	baseline	were	 significantly	higher	 both	 at	 6	 (p=0.013)	 and	24	hours	
(p=0.005)	after	the A. fumigatus	challenge	compared	to	the	placebo	(Table	6,	Figure	8).	
At	the	group	level,	significant	differences	in	changes	between	A. fumigatus	and	placebo	
challenges	were	 also	 seen	 in	 the	 control	 group	 at	 6	 (from	baseline	 24.1	 to	 47.9	 pg/
ml	vs.	from	baseline	69.6	to	26.2	pg/ml,	respectively,	p=0.01)	and	24	(from	baseline	
24.1	to	71.7	pg/ml,	from	baseline	69.2	to	22.2	pg/ml,	respectively,	p=0.008)	hours	after	
the	challenges	but	not	 in	 the	other	 study	groups.	 In	addition,	 there	was	a	 significant	
difference	in	baseline	levels	of	IL-1β	between	the	A. fumigatus	and	placebo	challenges	
(Table	6,	p=0.004).
	 	 	 There	was	 an	 increase	 of	 the	 IL-4	 concentrations	 in	NAL	 after	 the	A. fumigatus	
challenge	whereas	the	placebo	challenge	decreased	the	levels	(Table	6).	The	increase	
in	 IL-4	 levels	 tended	 to	be	higher	both	at	6	 (p=0.057)	 and	24	 (p=0.099)	hours	 after	
the	A. fumigatus	inhalation	as	compared	to	placebo	(Table	6).	In	the	group	of	subjects	
with	occupational	exposure	in	the	moisture-damaged	building,	there	was	a	significant	
difference	between	A. fumigatus	and	placebo	challenges	in	the	induced	changes	of	IL-4	
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levels	both	at	6	hours	(from	baseline	0.3	to	0.7	pg/ml	vs.	from	baseline	0.6	to	0.3	pg/ml,	
respectively,	p=0.046)	and	24	hours	(from	baseline	0.3	to	0.7	pg/ml	vs.	from	baseline	
0.6	 to	 0.2	 pg/ml,	 respectively,	 p=0.008)	 after	 the	 inhalations	when	 compared	 to	 the	
baseline	values	but	no	such	changes	were	found	in	the	other	study	groups.
			The	IL-6	levels	in	NAL	increased	after	the	A. fumigatus challenge	and	the	peak	levels	
were	achieved	6	hours	after	the	inhalation	(Table	6).	In	contrast,	IL-6	concentrations	
decreased	after	 the	placebo	challenge	compared	 to	baseline	 levels.	 If	all	 the	subjects	
were	examined	as	a	single	group,	then	the	change	in	IL-6	levels	tended	to	be	higher	at	6	
hours	after	the	A. fumigatus	challenge	compared	to	the	placebo	inhalation	(p=0.058).	No	
significant	changes	in	IL-6	concentrations	between	the	mould	and	placebo	challenges	
were	found	at	the	subgroup	level.
	 	 	 In	 all	 the	 subjects,	 the	TNF-α	 concentration	of	NAL	 increased	after	A. fumigatus	
challenge	and	decreased	slightly	after	the	placebo	inhalation	but	the	differences	did	not	
reach	statistical	significance	(Table	6).	However,	in	the	control	group,	the	change	from	
the	baseline	in	TNF-α	levels	was	significantly	higher	at		6	hours	after	the	A. fumigatus	
challenge	compared	to	the	placebo	challenge 	(from	baseline	8.8	to	18.6	pg/ml	vs.	from	
baseline	31.9	to	21.7	pg/ml,	respectively,	p=0.028).	In	the	other	subgroups	no	significant	
changes	in	TNF-α	concentrations	were	found	between	mould	and	placebo	challenges.
			Only	minor	changes	in	the	IFN-γ	levels	were	detected	after	A. fumigatus	or	placebo	
challenges	 and	 no	 significant	 differences	were	 noted	 at	 any	 time	 point	 between	 the	
challenges	(Table	6).
			When	the	atopic	subjects	were	treated	as	a	single	group	(i.e.	all	of	the	atopic	subjects	
with	or	without	previous	mould	exposure)	there	was	a	tendency	but	not	a	statistically	
significant	 difference	 between	A. fumigatus	 and	 placebo	 challenges	 in	 the	 extent	 of	
the	 changes	 of	 IL-1β	 levels	 at	 24	 hours	 after	 the	 challenges	 (from	 baseline	 19.9	 to	
34.8	pg/ml	vs.	from	baseline	27.7	to	23.2,	respectively,	p=0.066,	n=9).	No	significant	
differences	or	tendencies	in	changes	of	any	of	the	other	cytokine	between	the	mould	and	
placebo	challenges	were	founded	at	any	time	point	when	comparing	the	atopic	subjects	
to	the	other	subjects.
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Table	5.	Baseline	cytokine	levels	in	different	groups	before	the	first	challenge*	(III).
	 Mould	exposed	 Atopic	 Controls
Cytokine	 (n=13)	 (n=4)	 (n=10)
_____________________________________________________________________		
TNF-α**	 0.1	(0-0.6)	 0.3	(0-1.0)	 31.4	(0-230)
IL-1β	 19.7	(0-89)	 47.4	(1-150)	 51.5	(5.2-200)
IL-4	 0.4	(0-1.9)	 0.5	(0-1.9)	 14.7	(0-120)
IL-6	 7.2	(0-29.9)	 6.7	(0-18)	 69.3	(1.6-370)
IFN-γ		 7.3	(0-14.9)	 7.1	(0-16.9)	 8.1	(0-14.9)
_____________________________________________________________________		
Data	presented	as	mean	values	(range)	pg/ml
*Aspergillus fumigatus	and	placebo	challenges	were	performed	in	a	random	order
**significant	difference	between	the	groups	(p=0.029)
Figure 8. The changes of IL-1 levels from the baseline after the A. fumigatus and 
placebo challenges. There was a significant difference between the challenges measured 
at 6 (*, p=0.013) and 24 (**, p=0.005) hours later.
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Table	6.	Changes	in	cytokine	levels	6	and	24	hours	after	A.	fumigatus	and	placebo	
challenges	among	all	the	studied	subjects	(n=27)	(III).
Cytokine	 Challenge	 	 Baseline	 aChange		 bChange
	 	 	 	 6	hours	 24	hours
_____________________________________________________________________		
TNF-α	 A. fumigatus	 3.3	 3.6	 8.2
	 	 	 (0-52.7)	 (-7.7-42.2)	 (-17.5-150)
	 Placebo	 	 11.9	 -3.6	 -3.9
	 	 	 (0-230)	 (-87.4-8.1)	 (-190-46.9)
	 	 p-value	 0.064	 0.121	 0.379
IL-1β	 A. fumigatus	 18.1	 6.7	 23.7
	 	 	 (0-150)	 (-65.7-180)	 (-37.6-520)
	 Placebo	 	 38.3	 -15.3	 -19.0
	 	 	 (0.3-200)	 (-125.1-190)	 (-170-99.1)
	 	 p-value	 0.004	 0.013	 0.005
IL-4	 A. fumigatus	 1.5	 1.0	 1.1
	 	 	 (0-10)	 (-1.3-13)	 (-3.7-21)
	 Placebo	 	 5.8	 -2.9	 -4.1
	 	 	 (0-120)	 (-73.5-3.9)	 (-110-5.6)
	 	 p-value	 0.256	 0.057	 0.099
IL-6	 A. fumigatus	 8.1	 14.0	 8.3
	 	 	 (0-35.3)	 (-32-200)	 (-20.5-220)
	 Placebo	 	 31.1	 -18.4	 -13.2
	 	 	 (0-370)	 (-220-40.8)	 (-300-77.8)
	 	 p-value	 0.143	 0.058	 0.848
IFN-γ	 A. fumigatus	 7.4	 -0.2	 -0.1
	 	 	 (0-16.8)	 (-4.5-6.7)	 (-4-13.7)
	 Placebo	 	 7.5	 -0.2	 -0.3
	 	 	 (0-17.2)	 (-4.2-2.2)	 (-2.9-7.2)
	 	 p-value	 0.411	 1.000	 0.168
_____________________________________________________________________		
Data	presented	as	mean	values	(range)	pg/ml
p-values	 are	 for	 the	 differences	 between	A. fumigatus	 and	placebo	 challenges	 at	 the	
same	time	point	
aCytokine	concentration	[6	hours	after	challenge]	-		cytokine	concentration	[baseline]
bCytokine	concentration	[24	hours	after	challenge]	–	cytokine	concentration	[baseline]
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5.2.5	Cell	differential	count
			Neutrophilic	cells	dominated	the	NAL	cell	profile	both	before	and	after	the	A. fumigatus	
and	placebo	challenges.	No	changes	in	the	proportions	of	lymphocytes,	neutrophils	or	
eosinophils	 in	 the	NAL	were	 seen	 after	 the	 challenges.	Moreover,	 no	 differences	 in	
the	 changes	 of	 the	 cell	 counts	were	 detected	 between	 the	A. fumigatus	 and	 placebo	
challenges	(data	not	shown).
5.2.6	IgE	and	ECP	responses
			Serum	total	IgE	levels	were	significantly	higher	among	the	atopic	subjects	compared	
to	 subjects	 in	 the	 mould	 exposed	 and	 control	 groups	 (247.7	 IU/L,	 57.8	 and	 71.4,	
respectively,	p<0.05).	There	was	no	significant	difference	in	serum	ECP	concentrations	
between	the	groups	and	none	of	the	subjects	exhibited	elevated	A. fumigatus	IgE	levels	
(data	not	shown).
5.3	The	effects	of	PVC	challenge	(IV)
5.3.1	Symptoms	related	to	the	challenge
			The	number	of	subjects	reporting	respiratory	tract	symptoms	(such	as	nasal	symptoms,	
cough,	phlegm)	was	significantly	higher	on	the	following	morning	after	they	had	been	
exposed	 to	 the	 degrading	 PVC	material	 compared	 to	 the	 situation	 after	 the	 control	
exposure	(50	%	vs.	0	%,	respectively,	p=0.029,	n=10).	During	the	PVC	exposure	the	
subjects	experienced	more	often	respiratory	tract	and	conjunctival	symptoms	compared	
to	the	control	challenge	but	the	differences	did	not	reach	statistical	significance	(Table	
7).
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Table	7.	Symptoms	reported	by	the	subjects	during	espoxures	to	the	PVC	flooring	material	
and	placebo	(ceramic	tile)	and	on	the	following	morning	after	the	exposures	(IV).
	 PVC   Placebo	 p-value
	 flooring__________________
Symptoms	during	the	exposures:
Lower	Airway	 2	(20)	 0	(0)	 0.263
Upper	Airway	 7	(70)	 5	(50)	 0.430
Lower	and	Upper	Airway	 8	(80)	 5	(50)	 0.259
Fatigue	 1	(10)	 1	(10)	 0.737
Skin	 2	(20)	 2	(20)	 0.712
Eye	 3	(30)	 1	(10)	 0.333
Symptoms	on	the	morning	following	the	exposures:
Lower	and	Upper	Airway	 5	(50)	 0	(0)	 0.029
_____________________________________________________________________		
Data	presented	as	n	(%)
Table	 8.	 Cytokines	 (TNF-α,	 IL-4,	 IL-6	 and	 IL-12)	 (mean	 and	 range,	 pg/ml)	 and	
nitrite	 (NO)	 (mean	 and	 range,	 µM)	 in	 the	 nasal	 lavage	 samples	 of	 the	 study	 before	
and	immediately	after	the	challenges	to	PVC	and	control	material	(ceramic	tiles).	The	
results	also	show	the	values	of	a	sample	assessed	after	at	least	one	week’s	holiday	away	
from	the	workplace.
	 After	 Before	 After	 Before	 After
	 holiday	 PVC	 PVC	 control	 control
TNF-α		 179.7	 152.2		 267.2	 103.9	 177.5
	 (0-1208.8)	 (0-749.0)	 (0-1146.8)	 (0-517.6)	 (0-803.0)
IL-4	 51.6	 56.4	 102.9	 39.6	 80.1
	 (0-379.6)	 (0-276.4)	 (0-529.3)	 (0-234.7)	 (0-533.8)
IL-6	 76.9	 71.2	 108.6	 49.3	 106.4
	 (0.2-572.4)		 (0-383.9)	 (0.1-536.1)	 (0.5-278.4)	 (0-525.9)
IL-12	 308.4	 	413.1	 453.2	 171.8	 435.5
	 (0-1863.0)	 (0-2218.1)	 (0-2647.8)	 (0-1027.6)	 (0-2650.9)
NO	 6.8	 4.8	 6.6	 6.1	 4.9
	 (1.7-46.6)	 (1.6-10.1)	 (1.3-18.9)	 (1.0-18.0)	 (1.6-23.4)
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5.3.2	TVOC	and	2-ethylhexanol	concentrations
	 	 	 Concentrations	 of	TVOC	 and	 2-ethylhexanol	 in	 the	 chamber	 air	 during	 the	 PVC	
challenges	and	TVOC	during	the	control	(ceramic	tiles)	tests	are	shown	in	the	figure	
9.	During	 the	 control	 exposure,	 2-ethylhexanol	 concentrations	were	 very	 low	 in	 the	
chamber	air	(≤	2.4	µg/m3).	The	correlation	between	TVOC	levels	in	exposure	chamber	
and	in	exhaled	breath	samples	during	the	PVC	exposure	is	shown	in	figure	10.	Figure	
11	 shows	 the	 correlation	between	2-ethylhexanol	 concentrations	 in	 the	 chamber	 and	
their	concentrations	in	exhaled	breath	samples	during	the	exposure	to	damaged	PVC	
flooring	material.	During	the	PVC	exposure	tests,	all	of	the	exhaled	breath	samples	of	
the	subjects	studied	contained	2-ethylhexanol	with	the	concentration	ranging	from	1.2	
to	9.2	µg/m3	(mean	5.2	µg/m3).
Figure 9. Concentrations of TVOCs and 2-ethylhexanol during the PVC exposure and 
TVOCs during the control (ceramic tile) test in exposure chamber air.
Figure	9
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Figure	10
Figure 11. Correlation between 2-ethylhexanol concentrations in exposure chamber air 
and in exhaled breath samples during exposure to PVC. R2=0.4792.
Figure 10. Correlation between TVOCs in exposure chamber air and in exhaled breath 
samples duirng exposure to PVC. R2=0.84.
Figure	11
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5.3.3	Lung	Functions
			Before	the	PVC	flooring	challenge,	the	baseline	values	of	forced	expiratory	volume	in	
one	second	(FEV1)	were	109	%	and	forced	vital	capacity	(FVC)	120	%	of	the	predicted	
values.	The	 spirometric	 values	 did	 not	 change	 significantly	 during	or	 after	 the	PVC	
challenge,	 neither	 were	 there	 any	 significant	 differences	 in	 lung	 functions	 between	
the	PVC	and	 control	 exposures.	The	baseline	 levels	 of	 lung	 functions	did	not	 differ	
significantly	 in	 asthmatic	 subjects	 or	 smokers	 (including	 current	 and	 ex-smokers)	
compared	 to	 the	 others	 (data	 not	 shown).	 Moreover,	 PEF	 values	 did	 not	 change	
significantly	during	or	after	the	challenges,	and	there	was	no	significant	difference	in	
PEF	values	between	the	PVC	and	control	exposures	(data	not	shown).
5.3.4	FE
NO
	and	FN
NO
			The	FE
NO
	levels	did	not	change	significantly	during	or	after	the	PVC	challenge	and	no	
significant	difference	in	the	FE
NO
	concentrations	between	the	PVC	and	control	exposures	
(data	not	shown).	Furthermore,	there	were	no	significant	changes	in	FN
NO
	levels	during	
or	after	either	the	PVC	exposure,	nor	any	statistically	significant	difference	between	the	
PVC	and	control	challenges	(data	not	shown).
5.3.5	Cytokines,	NO	and	2-ethylhexanol	in	NAL
			The	levels	of	all	of	the	cytokines	in	NAL	(TNF-α,	IL-4,	IL-6	and	IL-12)	increased	
immediately	 after	 exposure	 to	 either	PVC	 flooring	or	 the	 control	material	 and	 there	
were	no	statistically	significant	differences	in	the	cytokine	concentrations	between	the	
challenges.	No	 changes	were	 detected	 in	NO	 concentrations	 of	NAL	 after	 the	 PVC	
exposure	nor	was	 there	any	statistically	significant	difference	when	compared	 to	 the	
control	situation	(Table	8).
			The	cytokine	and	NO	levels	in	NAL	of	samples	taken	after	at	least	one	week	vacation	
away	 from	 work	 did	 not	 differ	 from	 the	 baseline	 levels	 before	 the	 exposures.	 The	
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presence	of	2-ethylhexanol	in	the	NAL	samples	collected	after	the	PVC	exposure	was	
not	detected.
5.3.6	Cell	Differential	Count
			Neutrophilic	cells	dominated	the	NAL	cell	profile	both	before	and	after	both	exposures	
(i.e.	 PVC	 flooring	 and	 control).	 No	 changes	 in	 the	 proportions	 of	 lymphocytes,	
neutrophils	 or	 eosinophils	 in	 the	NAL	were	 seen	 after	 the	 challenges.	Moreover,	 no	
differences	were	detected	in	the	changes	in	the	cell	counts	between	the	PVC	and	control	
challenges	(data	not	shown).
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6.	DISCUSSION
		
			In	this	thesis,	the	reproducibility	of	the	studied	FE
NO
	and	FN
NO
	measurement	techniques	
was	 shown	 to	 be	 high.	Thus	 the	 techniques	 are	 suitable	 for	 long-term	 follow-up	 of	
an	individual’s	respiratory	tract	inflammatory	status	as	demonstrated	when	they	were	
utilized	in	the	studies	on	A. fumigatus	and	degraded	PVC	material	challenges.	It	was	
shown	that	inhalation	challenges	to	A. fumigatus provoked	inflammation	in	the	upper	
and	lower	respiratory	tract	as	indicated	by	increases	in	FE
NO
	and	NAL	cytokine	levels	
as	 well	 as	 the	 airway	 symptoms	 reported	 by	 the	 subjects	 in	 this	 study.	 Thus,	 FE
NO
	
measurement	may	serve	as	an	indicator	of	mould	exposure	and	the	changes	in	cytokine	
levels	 may	 provide	 a	 link	 between	 mould	 exposure	 and	 biochemical	 inflammatory	
markers.	In	the	other	experimental	study,	even	minuscule	exposure	to	degraded	PVC	
material	caused	inflammation	in	airways,	as	indicated	by	the	self-reported	symptoms	of	
the	subjects.		In	contrast,	minor	exposure	to	PVC	degradation	products	did	not	evoke	
inflammation	detectable	by	FE
NO
,	FN
NO
	or	cytokine	measurements.
6.1	Short	and	long-term	reproducibility	of	FE
NO
	and	FN
NO
	(I)
	 	 	The	 short-term	and	 seasonal	 reproducibilities	were	good	 for	 both	FE
NO
	 and	FN
NO	
measurements	in	healthy	subjects.	Due	to	the	strict	exclusion	criteria	used	the	present	
FE
NO
	and	FN
NO
	data	are	not	affected	by	inflammatory	interference	such	as	that	associated	
with	allergy	and	respiratory	tract	infections.	The	present	observations	of	both	day-to-
day	and	week-to-week	reproducibilities	of	FE
NO
	are	in	line	with	earlier	findings	showing	
high	 reproducibility	 of	 a	 single	 determination	 of	 FE
NO
	 (Gabbay	 et	 al.	 1998;	 Ekroos	
et	al.	2002)	as	well	as	of	the	week-to-week	reproducibility	of	the	FE
NO
	measurement	
(Ekroos	et	al.	2000).	However,	 in	 the	present	study,	 the	week-to-week	correlation	of	
FE
NO
	measured	in	the	afternoon	did	not	reach	a	clinically	significant	level.	It	has	been	
suggested	that	a	change	of	30-35	%	or	more	in	the	FE
NO
	levels	within	an	interval	of	1-3	
weeks	could	be	considered	abnormal	(Ekroos	et	al.	2000).
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			The	morning	levels	of	both	FE
NO
	and	FN
NO
	were	consistently	lower	than	those	measured	
in	the	afternoon	of	the	same	day.	The	difference	was	more	distinct	in	FN
NO
.	In	previous	
reports,	the	rise	in	the	NO	levels	during	the	day	has	been	attributed	to	dietary	as	well	as	
metabolic	factors	(Zetterquist	et	al.	1999;	Palm	et	al.	2000).	On	the	other	hand,	in	this	
study	the	FE
NO
	levels	did	not	rise	to	abnormal	levels	in	the	afternoons	in	comparison	to	
reference	values	(Kharitonov	et	al.	1997;	ATS	1999;	ATS/ERS	2005).	The	instrument	
used	in	this	study	was	calibrated	each	morning	and	from	time	to	time	in	the	afternoon	
and	no	drift	 in	 the	 values	was	 found.	Thus,	 the	 intraday	 changes	 in	 the	 nitric	 oxide	
levels	 are	 interpreted	 as	normal	physiological	variation.	 In	 contrast	with	our	 results,	
Kharitonov	et	al.	 (2003)	did	not	 find	any	diurnal	variation	 in	FE
NO
	 levels.	However,	
these	present	results	indicate	that	the	diurnal	variation	must	be	taken	into	consideration	
when	planning	clinical	trials.
			The	present	data	suggests	that	seasonal	changes	in	air	temperature	do	not	have	any	
impact	 on	 the	 physiological	NO	production	 in	 the	 lower	 airways.	This	 is	 of	 special	
interest,	since	cold	air	has	been	reported	to	be	associated	with	inflammatory	cell	leakage	
into	 bronchial	mucosa	 after	 exercise,	 but	 changes	 in	NO	 levels	 have	 not	 supported	
the	presence	of	active	inflammation	(Bonsignore	et	al.	2003).	It	must	be	noted	that	in	
Finland	temperature	and	humidity	varies	extensively	between	the	seasons.		According	
to	 the	Finnish	Meteorological	 Institute,	 the	mean	outdoor	 temperatures	 (years	1900-
2000)	in	the	area	that	the	study	was	performed	were	+9.0	C°	in	autumn	(September),	-
8.8	C°	in	winter	(January)	and	+16.5	C°	in	summer	(June).	In	Finland,	the	pollen	season	
lasts	from	the	beginning	of	May	until	the	end	of	August.	Thus,	significant	changes	in	
NO	levels	during	the	different	seasons	are	probably	related	to	airway	inflammation	such	
as	allergy,	asthma	and	respiratory	infections.
	 	 	 In	 line	with	 a	 previous	 study,	 the	 day-to-day	 and	week-to-week	 variations	 of	 the	
FN
NO
	levels	were	low	(Bartley	et	al.	1999).	However,	the	day-to-day	reproducibility	of	
FN
NO
	measured	in	the	afternoon	was	slightly	below	the	limit	of	clinical	significance.	
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Therefore,	as	with	the	FE
NO
	measurements,	it	is	advisable	to	perform	the	serial	FN
NO
	
measurements	in	the	morning	to	avoid	these	confounding	effects.
			The	seasonal	reproducibility	of	FN
NO
	measurement	was	high	in	this	healthy	population.	
Since	elevated	FN
NO
	concentrations	have	been	detected	in	subjects	with	allergic	rhinitis	
it	could	be	anticipated	that	the	FN
NO
	levels	vary	seasonally	in	such	patients.	However,	
Henriksen	 et	 al.	 (1999)	 did	 not	 find	 any	 elevation	 in	 FN
NO
	 levels	 during	 the	 pollen	
season	 in	subjects	with	allergic	 rhinitis	 though	among	 the	same	population	 the	FE
NO
	
levels	had	increased	as	expected.	In	this	study,	the	FN
NO
	levels	in	the	healthy	subjects	
were	not	affected	by	climatic	factors	such	as	cold	outdoor	temperature	or	the	presence	
of	pollen	in	the	air.
			FN
NO
	levels	were	high	compared	to	FE
NO
	levels	and	this	is	in	accordance	with	previous	
findings	(Lundberg	et	al.	1999;	Djupesland	et	al.	2001;	Jorissen	et	al.	2001).	This	study	
revealed	that	the	FN
NO
	and	FE
NO
	levels	did	not	correlate	with	each	other.	The	FN
NO
	and	
FE
NO
	 concentrations	 reflect	 the	 physiological	 status	 of	 the	 upper	 and	 lower	 airways	
respectively	and	NO	is	known	to	have	different	roles	in	the	upper	and	lower	airways.
			The	technique	for	FE
NO
	measurement	used	in	this	study	is	well-documented	and	the	
mean	FE
NO
	values	are	in	agreement	with	previous	studies	(Kharitonov	et	al.	1997;	ATS	
1999;	ATS/ERS	2005).	FN
NO
	levels	vary	between	laboratories	with	values	from	30	to	
2000	ppb	being	reported.	This	has	been	explained	as	being	due	to	different	measurement	
techniques	(Jorissen	et	al.	2001;	Kharitonov	et	al.	2005)	but	recently	detailed	instructions	
for	FN
NO
	measurement	have	been	provided	(ATS/ERS	2005).	According	to	an	earlier	
report,	higher	exhalation	flow	rates	in	FN
NO
	measurement	(250	vs.	500	mL/minute)	lead	
to	higher	intraday	and	inter-day	variability,	and	the	FN
NO
	levels	are	inversely	related	to	
the	flow	rate	(Zetterquist	et	al.	1999).	In	this	study,	for	the	FN
NO
	measurements	a	low,	
steady	flow	rate	of	100	mL/minute	was	used	in	order	to	minimize	the	variation	in	the	
FN
NO
	levels	and	this	partly	explains	the	high	reproducibility	of	the	present	results.
	 	 	The	methods	 used	 in	 this	 study	 for	 FE
NO
	 and	 FN
NO
	measurements	 require	 bulky,	
69
non-portable	 equipment	 even	 though	 the	 methods	 were	 highly	 reproducible.	 Novel	
portable	hand-held	devices	for	NO	measurements	have	been	developed	and,	in	future,	
they	will	represent	more	flexible	tools	for	monitoring	an	individual’s	respiratory	tract	
inflammation.
6.2	Inflammatory	airway	effects	caused	by	A. fumigatus challenge	(II	and	III)
			In	study	II,	A. fumigatus challenge	evoked	a	rapid	increase	in	FE
NO
	levels	and	there	
was	a	significant	difference	compared	to	the	placebo	test.	The	increased	FE
NO
	values	
indicate	 that	 inflammatory	 changes	 in	 lower	 airways	 had	 been	 induced	 by	 mould	
challenge.	A. fumigatus	has	been	reported	to	stimulate	NO	production	in	rat	alveolar	
macrophages	(Green	et	al.	1999).	The	results	of	this	thesis	are	also	in	line	with	a	study	
reporting	 increased	NO	 concentrations	 in	NAL	 in	 subjects	with	 occupational	mould	
exposure	 (Hirvonen	 et	 al.	 1999).	 This	 is	 of	 interest	 because	 increased	 FE
NO
	 levels	
are	 associated	with	 inflammatory	 lung	diseases	 such	 as	 asthma	 and	 respiratory	 tract	
infections	 (Kharitonov	 et	 al.	 1994;	Ricciardolo	 2003).	 In	 addition,	 a	 previous	 study	
reported	 that	 allergen	challenge	evoked	a	 late,	 though	not	 an	 immediate,	 increase	 in	
FE
NO
	values	in	asthmatic	subjects	(Paredi	et	al.	1999).
	 	 	 Baseline	 FE
NO
	 levels	 were	 slightly	 higher	 in	 comparison	 to	 ERS	 and	 ATS	
recommendations	(ATS	1999;	Kharitonov	et	al.	1999;	ATS/ERS	2005).	On	 the	other	
hand,	the	levels	did	not	differ	from	previous	measurements	in	the	same	laboratory	and	
the	differences	can	be	explained	by	ambient	NO	levels	(Purokivi	et	al.	2000).	There	was	
one	current	smoker	and	four	ex-smokers	among	the	subjects	of	studies	I	and	II.	Smoking	
decreases	FE
NO
	and	FN
NO
	levels	(Persson	et	al.	1994)	but	after	smoking	cessation	the	
values	rise	again	to	normal	levels	(Robbins	et	al.	1997).	Smoking	was	prohibited	during	
the	study	periods	and	thus	did	not	affect	the	results.
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	 	 	FN
NO	
levels	 increased	in	a	similar	way	after	mould	and	placebo	challenges	and	no	
significant	differences	were	found	between	these	two	exposures.	Consistently,	NO	in	
NAL	 did	 not	 change	 significantly	 after	 the	A. fumigatus	 inhalation.	The	 changes	 in	
FN
NO
	and	the	minor	increase	of	FE
NO
	after	the	placebo	challenge	have	been	attributed	
to	normal	diurnal	variation	(Palm	et	al.	2000),	a	conclusion	confirmed	by	the	results	of	
study	I	of	this	thesis.	In	summary,	the	inflammatory	changes	evoked	by	A. fumigatus	
cannot	be	detected	by	FN
NO
	measurement	or	by	assessing	NO	in	NAL.
	 	 	There	was	a	 significant	decrease	 in	FEV1	after	 the	mould	challenge	compared	 to	
placebo	inhalation	but	the	decrease	was	minor	when	observing	the	changes	in	absolute	
values.	On	the	other	hand,	exposure	to	various	bioaerosols	among	waste	collectors	was	
found	to	be	connected	with	a	significant	decrease	of	FEV1	levels	(Heldal	et	al.	2003).	
In	addition,	 in	study	II,	 the	baseline	FVC	and	FEV1	values	were	significantly	 lower	
among	the	mould	exposed	subjects	compared	to	their	controls.	However,	because	of	the	
small	group	sizes	the	baseline	FVC	and	FEV1	levels	are	poorly	comparable	with	those	
in	study	II.
			One	of	the	atopic	subjects	experienced	an	asthmatic	reaction	during	the	A. fumigatus	
challenge	(25	%	decrease	in	FEV1).	After	exclusion	of	this	subject,	there	was	no	longer	
a	significant	difference	in	FE
NO
	levels	between	the	challenges	but	a	distinct	tendency	
could	still	be	seen.	The	same	subject	had	also	a	relatively	large	decrease	in	FEV1	after	
placebo	challenge	(12	%).	This	is	an	indication	that	bronchial	hyperresponsiveness	is	
not	only	related	to	A. fumigatus,	but	nonetheless	the	decrease	in	FEV1	doubled	after	the	
A. fumigatus	challenge.	The	said	subject	belonged	to	the	group	of	atopic	subjects.	It	is	
well	established	that	some	non-asthmatic	atopic	subjects	may	have	subclinical	asthma	
not	previously	detected.	After	 the	exclusion	of	 the	subject	experiencing	an	asthmatic	
response	to	A. fumigatus	inhalation,	no	significant	difference	or	tendency	was	detected	
in	FEV1	values	between	the	challenges.	Thus,	it	cannot	be	claimed	that	A. fumigatus 
challenge	affects	lung	functions.
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			The	data	of	study	III	show	that	IL-1β	concentrations	in	the	NAL	increased	in	a	time	
dependent	manner	after	the	A. fumigatus	challenge	among	all	the	subjects.	IL-1β	is	a	
proinflammatory	 cytokine	mainly	 produced	 by	 airway	macrophages	 as	 a	 part	 of	 the	
nonspecific	inflammatory	response	(Opal	&	DePalo	2000).	A. fumigatus	is	also	known	
to	secrete	proteases	that	promote	the	release	of	proinflammatory	cytokines	(Schuh	et	
al.	2003).	In	a	previous	study,	increased	IL-1β	concentrations	in	NAL	were	found	in	
association	with	occupational	mould	exposure	(Purokivi	et	al.	2001).	IL-1β	is	also	known	
to	stimulate	production	of	NO	(Barnes	et	al.	1998).	In	accordance	with	the	findings	of	
this	 thesis	 it	 has	 been	 noted	 that	 an	 experimental	A. fumigatus	 challenge	 can	 cause	
a	 rapid	 increase	 in	FE
NO
	 levels.	Thus,	 it	can	be	proposed	 that	A. fumigatus exposure	
activates	IL-1β	production	which	is	involved	in	the	pathway	leading	to	inflammation	in	
the	upper	airways.
	 	 	TNF-α	 levels	 	 increased	 significantly	 at	 6	 hours	 after	 the	A. fumigatus challenge	
compared	to	placebo	inhalation	also	in	the	control	subjects	but	no	significant	responses	
were	 seen	 in	 all	 the	 subjects	 or	 in	 the	 other	 subgroups.	The	 elevated	TNF-α	 levels	
were	found	to	parallel	to	the	increased	IL-1β	concentrations	since	both	cytokines	are	
proinflammatory	 and	 are	 activated	 as	 a	part	 of	 the	 immune	 response	 against	 stimuli	
such	 as	microbial	 infections	 (Sedgwick	 et	 al.	 2002).	 In	 addition,	 IL-1β	 is	 known	 to	
promote	 the	 production	 of	TNF-α	 (Yoshimura	 et	 al.	 2003).	 In	 accordance	with	 this	
study,	elevated	TNF-α	concentrations	in	NAL	have	been	observed	in	association	with	
microbial	 exposure	 in	 a	moisture-damaged	 building	 (Purokivi	 et	 al.	 2001)	 and	 after	
exposure	to	swine	dust	(Wang	et	al.	1997).
			The	IL-6	levels	in	NAL	of	all	the	subjects	tended	to	be	higher	after	the	A. fumigatus	
challenge	 in	 comparison	 to	placebo	but	no	 significant	differences	were	 found	 in	 the	
changes	 of	 IL-6	 production	 between	 the	 challenges	 at	 the	 group	 level.	 IL-6	 is	 also	
considered	to	be	a	proinflammatory	cytokine	and	the	increased	levels	are	in	line	with	the	
changes	of	IL-1β	and	TNF-α.	On	the	other	hand,	IL-6	inhibits	TNF-α	and	IL-1β	and	may	
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protect	host	cells	from	potentially	destructive	inflammatory	responses	(Opal	&	DePalo	
2000).	Previous	reports	have	also	shown	a	significant	elevation	of	IL-6	in	NAL	among	
subjects	exposed	to	the	microbes	present	in	a	moisture-damaged	building	(Hirvonen	et	
al.	1999;	Purokivi	et	al.	2001;	Roponen	et	al.	2001).	Moreover,	consistent	with	results	of	
study	III,	increased	IL-6	concentrations	have	been	measured	from	airway	epithelial	cell	
lines	after	acute	A. fumigatus	challenge	(Borger	et	al.	1999).	In	summary,	the	present	
data	supports	the	hypothesis	that	proinflammatory	cytokines	play	a	significant	role	in	
the	inflammation	occurring	in	the	upper	airways	after	A. fumigatus	challenge.
			The	increased	IL-4	levels	in	NAL	observed	after	A. fumigatus challenge	are	similiar	to	
the	findings	of	a	previous	study	showing	a	link	between	elevated	IL-4	concentrations	in	
NAL	and	occupational	exposure	to	microbes	in	a	moisture-damaged	building	(Roponen	
et	al.	2001).	This	is	of	interest	since	IL-4	is	a	Th2-type	cytokine	that	is	known	to	be	
activated	in	allergy	and	atopic	diseases	(Olivenstein	et	al.	1999).	In	addition,	the	Th2-
type	 response,	 including	 the	elevated	 IL-4	 levels	dominates	 the	 immune	 response	 in	
A. fumigatus	 induced	 diseases	 such	 as	 pulmonary	 aspergillosis	 (Schuh	 et	 al.	 2003).	
The	changes	in	IL-4	levels	after	the	A. fumigatus challenge	were	most	distinct	in	the	
occupants	of	the	moisture-damaged	building.	Therefore,	inflammation	caused	by	acute	
mould	challenge	may	be	 linked	 to	 a	Th2-type	 response	 in	 individuals	with	previous	
chronic	mould	exposure.
			IFN-γ	is	known	to	inhibit	cell	proliferation	and	IL-4	production	and	also	to	enhance	
the	cytotoxicity	of	TNF-α	(Yoshimura	et	al.	2003).	In	study	III,	no	changes	of	IFN-γ	
levels	in	NAL	after	the	A. fumigatus	challenge	were	detected	and	the	responses	were	
similar	to	those	noted	after	the	placebo	inhalation.	This	is	in	agreement	with	the	results	
seen	in	mouse	models	where	increased	IL-4,	IL-5,	IL-10	and	IL-13	levels	have	been	
detected	after	acute	A. fumigatus	exposure	but	IFN-γ	levels	remained	unaffected	(Kurup	
et	al.	1994;	Grunig	et	al.	1997).
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	 	 	 In	 study	 III,	 there	were	 differences	 between	 the	 groups	 in	 the	measured	 baseline	
cytokine	 levels	which	were	highest	 among	 the	 control	 subjects.	This	may	be	due	 to	
several	factors.	The	quality	of	NAL	samples	received	from	atopic	and	occupationally	
mould	exposed	subjects	was	lower	than	the	samples	of	the	control	subjects	which	may	
be	reflected	in	the	cytokine	concentrations	obtained.	It	has	been	shown	in	a	previous	
study	 that	 there	may	be	considerable	differences	 in	cytokine	baseline	 levels	 in	NAL	
even	between	healthy	individuals	(Roponen	et	al.	2003).	It	can	also	be	assumed	that	the	
anatomy	of	each	subject's	nasal	cavity	may	contribute	to	the	between-subject	variability,	
since	 the	 same	volume	of	 the	 instilled	 fluid	may	 lavage	 a	different	 total	 area	of	 the	
nasal	 cavity	 in	different	 individuals.	However,	because	of	 the	 small	group	 sizes,	 the	
differences	in	cytokine	baseline	levels	before	the	first	challenge	are	not	comparable.
			In	study	III,	the	cytokine	concentrations	in	NAL	decreased	at	6	hours	after	the	placebo	
challenge	and	 returned	at	24	hours	 towards	 the	 level	which	had	been	present	before	
the	 challenge.	 In	 addition,	 there	was	 only	 a	 slight	 increase	 in	 the	 detected	 cytokine	
concentrations	after	the	A. fumigatus	inhalation	at	6	hours	possibly	due	to	an	attenuation	
of	 the	 responses	 caused	 by	 reperforming	 the	 NAL	 protocol	 6	 hours	 after	 the	 first	
sampling.	Thus,	6	hours	is	probably	too	short	a	time	to	allow	for	recovery	after	the	first	
nasal	lavage.	The	biological	basis	of	this	phenomenon	remains	unknown.
			Within-subject	variation	of	cytokine	levels	in	serial	NAL	measurements	is	low	but	
there	may	 be	 a	major	 variation	 between	 individuals	 and	 genders.	 Baseline	 cytokine	
concentrations	 in	 NAL	 have	 been	 reported	 to	 be	 significantly	 higher	 among	 males	
compared	to	females	(Roponen	et	al.	2003).	Thus,	in	study	III,	one	male	subject	with	
high	cytokine	baseline	values	was	excluded	and	thus	all	the	subjects	in	that	study	were	
females.		In	addition,	there	are	differences	between	NAL	sampling	methods	as	to	how	
the	samples	are	obtained,	handled	and	analyzed	(Roponen	et	al.	2003).	Thus,	there	are	
no	universal	reference	values	for	levels	of	cytokines	in	NAL	and	the	laboratory	specific	
validation	of	the	method	remains	crucial.
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	 	 	 The	 group	 to	 which	 the	 subjects	 belonged	 was	 not	 associated	 with	 significantly	
increased	FE
NO
	levels.	For	example,	it	could	have	been	anticipated	that	atopic	subjects	
would	exhibit	a	different	response	to	the	mould	challenge.	It	is	well	known	that	atopic	
status	as	such	is	connected	with	increased	FE
NO
	values	(Riccardolo	2003).	In	addition,	
Piipari	et	al.	 (2002)	 reported	 that	 those	 individuals	with	higher	baseline	FE
NO
	values	
displayed	only	a	minor	increase	in	FE
NO
	compared	to	those	with	lower	baseline	levels	
after	mould	challenge	including	A. fumigatus.	Consistently,	in	study	III,	a	tendency	was	
seen	in	IL-1β	levels	but	no	significant	changes	in	cytokine	concentrations	among	the	
atopic	subjects	including	those	with	and	without	mould	exposure	were	detected	after	
the	mould	challenge.	On	the	other	hand,	due	to	the	exclusion	criteria	the	group	of	atopic	
subjects	became	smaller	than	planned	and,	therefore,	it	was	not	feasible	to	perform	a	
comprehensive	statistical	analysis.
   A. fumigatus-induced	 airway	 inflammation	 is	 known	 to	 be	 associated	 with	 e.g.	
eosinophilia	(Schuh	et	al.	2003).	Therefore,	one	might	have	expected	to	see	changes	in	
nasal	cell	proportions	after	mould	challenge	since	clear	changes	in	cytokines	in	NAL	
were	detected	in	this	study.	However,	no	significant	differences	in	the	changes	of	cell	
differential	counts	in	NAL	between	the	A. fumigatus	and	placebo	challenges	were	found.	
On	the	other	hand,	consistent	with	the	current	results,	there	are	several	previous	studies	
where	mould	exposure	has	been	found	to	significantly	increase	cytokine	concentrations	
in	NAL	but	 the	 proportions	 of	NAL	 cells	 have	 remained	 unaltered	 (Hirvonen	 et	 al.	
1999;	Purokivi	et	al.	2001;	Roponen	et	al.	2001).	This	suggests	that	the	proportions	of	
nasal	lavage	cells	do	not	necessarily	represent	the	proportion	of	all	the	cells	in	the	nasal	
cavity	contributing	to	the	cytokine	concentrations	detected	in	NAL.
	 	 	 In	 line	 with	 the	 increased	 FE
NO
	 and	 cytokine	 concentrations,	 respiratory	 tract	
symptoms	on	the	morning	after	the	challenge	were	significantly	more	common	after	the	
A. fumigatus	inhalation	compared	with	the	placebo	test	in	all	of	the	studied	groups.	This	
finding	is	also	supported	by	previous	studies	establishing	that	subjects	exposed	to	indoor	
air	microbes	report	airway	symptoms	more	frequently	than	their	control	counterparts	
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and,	consistent	with	this	thesis,	the	symptoms	were	associated	with	increased	cytokine	
levels	(Hirvonen	et	al.	1999;	Purokivi	et	al.	2001;	Roponen	et	al.	2001).
	 	 	 It	 has	 been	 suggested	 that	 exposure	 to	 the	 indoor	 air	 fungi	 of	moisture-damaged	
buildings	can	cause	an	IgE	mediated	allergic	reaction	(Zureik	et	al.	2002).	In	our	study,	
none	of	the	subjects	had	increased	A. fumigatus	specific	IgE	levels,	and	only	one	subject	
in	the	group	of	mould	exposed	individuals	exhibited	a	positive	reaction	to	the	fungus	
Geotrichum candidum	 in	 skin	 prick	 tests.	There	 is	 also	 epidemiologic	 evidence	 that	
sensitization	to	A. fumigatus	as	well	as	to	Cladosporium herbarum	indicated	by	specific	
IgE	is	related	to	the	risk	of	adult-onset	asthma	(Jaakkola	et	al.	2006).	On	the	other	hand,	it	
has	been	reported	that	fungal	allergy	is	rare	in	individuals	exposed	to	mould	in	a	moisture-
damaged	school	(Immonen	et	al.	2000).	This	suggests	that	there	are	mechanisms	other	
than	immediate	IgE-type	reaction	evoking	the	respiratory	symptoms	after	exposure	to	
indoor	air	fungi	of	moisture-damaged	buildings.	Nonetheless,	it	has	been	reported	that	
sinusitis	among	teachers	with	occupational	mould	exposure	is	associated	with	increased	
fungal	 specific	 IgG	antibodies	 (Patovirta	 et	 al.	 2003).	 In	 a	Finnish	population-based	
incident	case-control	study	an	 increased	risk	of	developing	asthma	 in	adulthood	was	
significantly	related	to	IgG	antibodies	to	T. citrinoviride,	but	not	to	the	other	moulds	
including	 A. fumigatus,	 A. versicolor,	 Cladosporium cladosporioides,	 Fusarium 
oxysporum,	Sporobolomyces salmonicolor,	Stachybotrys chartarum,	and	Streptomyces 
albus (Jaakkola	et	al.	2002).	However,	the	presence	of	fungal	IgG	antibodies	in	human	
sera	indicates	only	that	exposure	has	occurred	at	some	time	in	the	past	(Jarvis	and	Miller	
2004).	In	addition,	only	a	few	fungal	allergens	have	been	accurately	characterized	with	
respect	 to	 their	 various	morphology	 and	 antigenicity	 as	 well	 as	 prevalent	 antigenic	
crossreactivity	(Malling	1992).	Furthermore,	part	of	the	IgE	binding	to	mould	and	yeast	
allergen	extracts	is	due	to	cross-reaction	with	glycoproteins	and	the	possibility	of	false-
positive	IgE	and	skin	prick	test	results	needs	be	taken	into	account	in	any	diagnosis	of	
mould	allergy	(Leino	et	al.	2006).
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			Microbial	extracts	from	moisture-damaged	buildings	produce	secondary	metabolites	
which	are	known	to	be	harmful	to	human	health	(Hendry	and	Cole	1993;	Fischer	et	al.	
2000).	Since	they	may	provoke	unexpected	health	effects	 it	 is	unethical	 to	challenge	
human	beings	with	these	extracts,	and	a	purified	A. fumigatus product	i.e.	a	product	not	
containing	e.g.	mycotoxins	was	used	in	this	study.	Due	to	commercial	considerations,	
the	exact	contents	of	the	extract	were	not	revealed	by	the	manufacturer	but	the	approval	
of	the	Finnish	National	Agency	for	Medicine	(FNAM)	for	the	product	guarantees	the	
safety	of	the	challenging	agent.
	 	 	Mycotoxins	 secreted	by	A. fumigatus	 could	have	potentially	caused	 inflammatory	
responses	 that	were	 not	 capable	 of	 being	 detected	 in	 this	 study.	 In	 addition,	 several	
batches	of	the A. fumigatus	were	used	and	there	may	be	differences	between	batches.	
Unfortunately,	the	possible	variation	between	the	batches	is	also	unknown	for	the	same	
commercial	reasons.	However,	this	thesis	demonstrates	that	inhalation	exposure	to	A. 
fumigatus	extract	without	secondary	metabolites	is	sufficient	to	evoke	respiratory	tract	
inflammation	even	if	there	may	be	possible	differences	between	batches.	
6.3	The	effects	of	degraded	PVC	material	challenge	on	airways	(IV)
			Ten	subjects	exposed	to	degraded	PVC	flooring	material	at	work	were	challenged	to	
PVC	under	controlled	conditions.	This	is	the	first	study	to	expose	subjects	to	very	low	
concentrations	of	chemical	emissions	similar	to	those	found	in	indoor	air	conditions.
			The	morning	following	the	PVC	challenge,	the	subjects	suffered	significantly	more	
often	respiratory	tract	symptoms	compared	to	the	situation	after	control	exposure.	This	
result	is	in	agreement	with	studies	where	the	subjects	have	experienced	similar	irritation	
symptoms	during	the	exposure	to	damaged	PVC	products	(Wieslander	et	al.	1999;	W
linder	et	al.	1999;	Bornehag	et	al.	2005).	According	to	the	results	of	this	study,	even	
minuscule	emissions	of	degraded	PVC	flooring	materials	which	may	be	found	in	indoor	
air	are	sufficient	to	evoke	respiratory	tract	symptoms.
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	 	 	The	PVC	and	control	 test	were	performed	blindly	and	 in	a	 random	order	but	 it	 is	
possible	 that	 the	 subjects	 recognized	 the	 degraded	 PVC	 material	 due	 to	 its	 smell.	
However,	no	significant	differences	were	found	between	PVC	and	control	tests	in	self-
reported	irritation	symptoms	during	the	exposures.	Instead,	the	significant	differences	
in	symptoms	were	found	on	the	morning	after	the	challenges.	Therefore,	it	seems	likely	
that	the	results	have	not	been	biased	by	the	fact	that	the	subjects	were	possibly	aware	of	
material	to	which	they	were	challenged.
			The	PVC	flooring	material	challenge	did	not	cause	any	significant	changes	in	lung	
functions,	 FE
NO
	 or	 FN
NO
	 levels	when	 compared	 to	 the	 control	 test.	Moreover,	 there	
were	no	individual	asthmatic	reactions	such	as	any	decrease	in	FEV1	after	these	short	
exposure	times,	although	half	of	the	subjects	had	asthma	and	their	asthma	medications	
had	been	withdrawn	prior	to	the	study.	In	occupational	exposures,	the	development	of	
asthma	requires	long	and	repeated	exposure	and	the	situation	may	be	similar	when	the	
occupants	are	exposed	to	the	damaged	PVC	material	(Tuomainen	et	al.	2004).	There	
is	clear	evidence	 that	damaged	PVC	products	are	associated	with	asthma	and	atopic	
disorders	(ie	et	al.	1997;	Bornehag	et	al.	2004).
			The	baseline	FE
NO
	levels	were	slightly	higher	than	the	normal	levels	defined	by	the	
ATS	and	ERS	recommendations	(Kharitonov	et	al.	1997;	ATS	1999;	ATS/ERS	2005).	
This	is	probably	due	to	the	presence	of	five	subjects	with	asthma	in	the	studied	group.	
The	baseline	FN
NO
	levels	were	also	higher	than	those	reported	in	study	II	of	this	thesis.	
There	were	two	subjects	with	very	high	FN
NO
	values	which	increased	the	mean	levels	
of	this	small	study	group.
			Cytokine	concentrations	in	NAL	increased	after	both	PVC	and	control	exposures	but	
no	significant	differences	 in	cytokine	 levels	attributable	 to	 the	active	challenge	were	
detected.	Consistent	with	unaltered	FN
NO
	levels,	the	degraded	PVC	material	challenge	
did	not	change	the	NO	concentrations	in	NAL.	Moreover,	the	cytokine	or	NO	levels	in	
NAL	after	a	vacation	did	not	differ	from	the	baseline	levels	taken	before	the	challenges.	
The	 timing	of	 the	NAL	samplings	was	not	 entirely	optimal	because	on	 the	morning	
following	 the	 PVC	 exposure	 the	 subjects	 reported	 a	 great	many	 of	 respiratory	 tract	
symptoms	but	at	that	time	no	NAL	samples	were	collected.	
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			Ceramic	tile	was	selected	as	the	control	material	because	it	was	considered	to	represent	
a	“clean”	material	with	very	 low	emissions.	However,	 it	 is	possible	 that	exposure	 to	
ceramic	tiles	also	evoked	inflammatory	changes	which	were	seen	as	increased	cytokine	
levels	in	NAL.	Thus	another	material	may	be	more	appropriate	for	use	as	control.	On	the	
other	hand,	it	is	possible	that	the	minuscule	PVC	exposure	does	not	cause	inflammation	
in	upper	airways	which	could	be	detected	as	increased	cytokine	or	NO	concentrations	
in	NAL.
			No	2-ethylhexanol	was	found	in	the	NAL	samples	collected	after	the	PVC	challenge.	
The	compound	could	have	already	evaporated	from	the	nose	before	the	sampling	which	
was	performed	after	the	lung	function	tests	and	FE
NO
	and	FN
NO
	measurements.	It	is	also	
possible	that	at	least	part	of	the	compound	had	been	absorbed	into	the	blood	circulation.	
All	of	the	exhaled	breath	samples	collected	during	the	PVC	exposure	contained	traces	of	
2-ethylhexanol.	The	presence	of	2-ethylhexanol	in	exhaled	breath	is	evidence	that	this	
compound	had	been	breathed	into	the	lungs,	transferred	into	blood	and	then	transported	
to	other	parts	of	the	body.	It	is	known	to	be	a	specific,	biologic	marker	for	exposure	to	
damaged	PVC	flooring	material	and	its	presence	describes	recent	exposure	(Wiglusz	et	
al.	1998).	In	normal	situations	(i.e.	when	there	is	no	exposure),	there	is	no	2-ethylhexanol	
present	in	exhaled	breath	(Phillips	et	al.	1999).	Although	there	were	only	ten	subjects	
in	this	study,	the	exhaled	breath	2-ethylhexanol	concentrations	correlated	well	with	the	
chamber	air	2-ethylhexanol	levels.	In	spite	of	the	ventilation	of	the	exposure	chamber	
after	PVC	exposures,	there	were	still	minimal	concentrations	of	2-ethylhexanol	in	the	
chamber	air	at	the	time	the	control	tests	were	performed.	These	low	levels	are	probably	
not	due	to	emissions	from	ceramic	tiles	but	are	more	likely	connected	to	the	air	exchange	
in	the	exposure	chamber.
6.4.	CLINICAL	IMPORTANCE	OF	THE	CURRENT	RESULTS
			FE
NO
	levels	are	known	to	increase	in	inflammatory	airway	diseases	such	as	asthma	
and,	 thus,	 they	 are	 widely	 measured	 in	 clinical	 work	 (ATS/ERS	 2005).	 Inhaled	
corticosteroids	 decline	 FE
NO	
concentrations	 in	 asthmatic	 individuals	 and	 low	 levels	
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during	the	treatment	demonstrate	a	good	steroid	response	(Kharitonov	et	al.	1994;	Fabio	
et	al.	2004).	Repeated	FE
NO
	measurements	are	well	appropriate	to	treatment	follow-up	
of	asthmatic	patients	due	to	the	high	long-term	reproducibility	indicated	in	this	study.	In	
the	study	I,	it	was	also	shown	that	FN
NO
	measurements	were	higly	repeatable.	However,	
there	are	controversial	results	about	how	FN
NO
	changes	in	inflammatory	upper-airway	
diseases	and	partly	because	of	 that	 the	FN
NO
	measurements	are	not	routinely	used	in	
clinical	work	(Djupesland	et	al.	1999;	Jorissen	et	al.	2001;	ATS/ERS	2005).
   A. fumigatus	is	a	common	fungus	found	in	mouldy	building	materials	(Hyvrinen	et	
al.	1999).	As	stated	in	this	thesis,	increase	in	FE
NO
	levels	may	indicate	an	acute	exposure	
to	that	fungus.	Nowadays,	there	are	portable	nitric	oxide	measurement	devices	which	
provide	a	possibility	for	measurements	inside	the	moisture-damaged	buildings	(Alving	
et	al.	2006).	On	ground	of	the	study	II,	the	first	FE
NO
	measurements	could	be	performed	
when	the	occupants	enter	the	building	and	the	second	time	at	3	hours	after	the	exposure.	
If	a	rapid	increase	in	FE
NO
	levels	is	observed	it	may	indicate	a	mould	exposure.	However,	
the	occupants	of	a	moisture-damaged	building	are	exposed	to	several	different	indoor	air	
microbes	and	their	secondary	metabolites.	Thus,	further	studies	are	needed	to	indicate	if	
a	real	life	mould	exposure	can	be	demonstrated	by	assessing	changes	in	FE
NO
	levels.
			The	changes	in	cytokine	levels	of	NAL,	especially	IL-1β,	may	also	be	indicators	of	
exposure	to	mould.	However,	NAL	is	technically	difficult	to	perform	and,	thus,	it	is	not	
easily	suited	for	clinical	examination	of	mould	exposed	individuals.	According	to	this	
thesis,	changes	of	FN
NO
	levels	do	not	indicate	an	exposure	to	A. fumigatus..
			In	the	study	IV,	degraded	PVC	materials	provoked	respiratory	tract	symptoms	in	the	
exposed	individuals.	Thus,	it	would	be	useful	to	replace	surfacings	containing	PVC	to	
less	harmful	materials	in	older	buildings	and	PVC	materials	should	be	avoided	when	
setting	up	new	buildings.	Interestingly,	the	study	IV	of	this	thesis	was	referred	to	when	
Prague	University	Hospital	Motol	informed	that	it	substituted	PVC	floors	by	harmless	
rubber	(Arnika	Press	Releases	2007).	The	biological	inflammatory	changes	caused	by	
degraded	PVC	materials	are	still	unknown	and,	thus,	need	further	research.	
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7.	CONCLUSIONS
			1.	Short-term	and	seasonal	reproducibilities	of	FE
NO
	and	FN
NO
	levels	are	very	high	and	
serial	NO	measurements	are	a	reliable	tool	in	monitoring	airway	inflammation	in	both	
upper	and	lower	airways.	The	diurnal	variation	needs	to	be	taken	into	account	such	that	
in	long-term	follow-up,	the	measurements	should	be	performed	at	the	same	time	of	the	
day,	in	the	preferably	mornings	rather	than	the	afternoons.
			2.	Inhalation	of	A. fumigatus	solution	evokes	inflammatory	changes	in	lower	airways	
seen	as	a	rapid	increase	in	FE
NO
	levels	and	respiratory	tract	irritation	symptoms	reported	
by	the	challenged	subjects.	FE
NO
	measurement	may	serve	as	an	indicator	of	acute	mould	
exposure.
	 	 	3.	A. fumigatus	challenge	causes	 inflammation	 in	 the	upper	airways	which	can	be	
detected	 as	 increased	 cytokine	 levels	 in	NAL	with	 the	most	 distinct	 response	 being	
seen	in	IL-1β	levels.	These	results	provide	a	link	between	acute	mould	exposure	and	
biochemical	markers	of	inflammation.
	 	 	 4.	Minuscule	 emissions	 of	 degraded	PVC	 flooring	materials	 that	 can	 be	 detected	
in	 the	 indoor	 air	 are	 sufficient	 to	 evoke	 respiratory	 tract	 irritation	 symptoms	 in	 the	
exposed	subjects.	Exposure	to	small	amounts	of	degrading	PVC	material	do	not	cause	
airway	inflammation	as	assessed	by	induced	changes	in	cytokines,	FE
NO
,	FN
NO
	and	lung	
functions.
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